strict digraph "" {
	graph [bb="0,0,3014.7,2933.6"];
	node [label="\N"];
	" cyclin d1 "	[height=0.5,
		pos="1001.3,1897",
		width=1.336];
	" potential targets "	[height=0.5,
		pos="1059.6,1838.8",
		width=2.004];
	" cyclin d1 " -> " potential targets "	[label=" also emerge ",
		lp="989.57,1864.3",
		pos="e,1041.9,1856.5 1018.5,1879.9 1023.5,1874.8 1029.2,1869.1 1034.7,1863.7"];
	" key potential targets "	[height=0.5,
		pos="921.62,1913.7",
		width=2.4192];
	" cyclin d1 " -> " key potential targets "	[label=" also emerge ",
		lp="922,1913.4",
		pos="e,958.66,1906 959.11,1905.9 959.03,1905.9 958.96,1905.9 958.88,1905.9"];
	" focus "	[height=0.5,
		pos="1006.6,1977.2",
		width=0.95686];
	" cyclin d1 " -> " focus "	[label=" upregulation ",
		lp="965.61,1939.5",
		pos="e,1005.4,1959 1002.5,1915.2 1003.1,1925.1 1004,1937.7 1004.7,1948.9"];
	" myc "	[height=0.5,
		pos="1129.6,1783.2",
		width=0.86659];
	" myc " -> " potential targets "	[label=" emerge ",
		lp="1075.7,1799",
		pos="e,1081.4,1821.5 1111.2,1797.8 1104.5,1803.1 1096.7,1809.3 1089.3,1815.3"];
	" inhibition "	[height=0.5,
		pos="1123.8,1505.4",
		width=1.3902];
	" myeloma cells translocation "	[height=0.5,
		pos="1211.9,1523.3",
		width=3.2136];
	" inhibition " -> " myeloma cells translocation "	[label=" effective ",
		lp="1195.1,1521.8",
		pos="e,1167.8,1514.3 1167.6,1514.3 1167.6,1514.3 1167.7,1514.3 1167.7,1514.3"];
	" myeloma cells "	[height=0.5,
		pos="1178.9,1497.3",
		width=1.8776];
	" inhibition " -> " myeloma cells "	[label=" effective ",
		lp="1142.9,1491",
		pos="e,1170.8,1498.5 1170.3,1498.6 1170.4,1498.5 1170.4,1498.5 1170.5,1498.5"];
	" significant dose-dependent tumor growth inhibition "	[height=0.5,
		pos="1036.2,1493.1",
		width=5.4884];
	" inhibition " -> " significant dose-dependent tumor growth inhibition "	[label=" cause ",
		lp="1057.8,1491.3",
		pos="e,1076.5,1498.7 1076.9,1498.8 1076.9,1498.8 1076.8,1498.8 1076.7,1498.7"];
	" significant tumor growth inhibition "	[height=0.5,
		pos="1089.2,1433.7",
		width=3.8816];
	" inhibition " -> " significant tumor growth inhibition "	[label=" cause ",
		lp="1089.8,1466.7",
		pos="e,1098.1,1452.1 1115.1,1487.3 1111.3,1479.4 1106.7,1469.9 1102.5,1461.2"];
	" dose-dependent tumor growth inhibition "	[height=0.5,
		pos="1062.3,1451.9",
		width=4.4052];
	" inhibition " -> " dose-dependent tumor growth inhibition "	[label=" cause ",
		lp="1078.5,1475.1",
		pos="e,1083.1,1470 1104.3,1488.5 1100,1484.7 1095.3,1480.7 1090.7,1476.7"];
	" tumor growth inhibition "	[height=0.5,
		pos="1035.9,1526.8",
		width=2.7984];
	" inhibition " -> " tumor growth inhibition "	[label=" cause ",
		lp="1063.1,1523",
		pos="e,1081.9,1515.6 1082.2,1515.5 1082.1,1515.5 1082.1,1515.5 1082,1515.5"];
	" gastric cancer "	[height=0.5,
		pos="956.18,1494.5",
		width=1.7873];
	" significant dose-dependent tumor growth inhibition " -> " gastric cancer "	[label=" survival ",
		lp="930.23,1487",
		pos="e,956.19,1494.5 956.24,1494.5 956.23,1494.5 956.22,1494.5 956.21,1494.5"];
	" cancer "	[height=0.5,
		pos="1006.5,1397.8",
		width=1.0652];
	" significant tumor growth inhibition " -> " cancer "	[label=" increase survival ",
		lp="1096.9,1407.8",
		pos="e,1035.1,1410.3 1049.3,1416.4 1047.7,1415.7 1046,1415 1044.4,1414.3"];
	" dose-dependent tumor growth inhibition " -> " cancer "	[label=" increase survival ",
		lp="987.14,1420",
		pos="e,1023.3,1414.1 1043.7,1433.9 1039.5,1429.8 1035,1425.4 1030.5,1421.1"];
	" tumor growth inhibition " -> " gastric cancer "	[label=" increase survival ",
		lp="944.98,1517.7",
		pos="e,992.82,1509.3 995.12,1510.3 995.03,1510.2 994.93,1510.2 994.83,1510.1"];
	" targeted inhibition "	[height=0.5,
		pos="1295.3,1537.7",
		width=2.2387];
	" targeted inhibition " -> " myeloma cells translocation "	[label=" effective ",
		lp="1258.6,1534.1",
		pos="e,1230.9,1526.6 1231.2,1526.7 1231.2,1526.7 1231.1,1526.6 1231.1,1526.6"];
	" extra protein antagonists "	[height=0.5,
		pos="2489.4,1042.7",
		width=2.8525];
	" promising anti-myeloma activity "	[height=0.5,
		pos="2520,957.63",
		width=3.683];
	" extra protein antagonists " -> " promising anti-myeloma activity "	[label=" display ",
		lp="2526.5,1012.5",
		pos="e,2513.5,975.64 2495.9,1024.6 2500,1013.3 2505.4,998.31 2510,985.42"];
	" expression "	[height=0.5,
		pos="2388.3,1032.7",
		width=1.4804];
	" extra protein antagonists " -> " expression "	[label=" decrease ",
		lp="2371.9,1041.3",
		pos="e,2399.2,1033.8 2399.5,1033.8 2399.4,1033.8 2399.4,1033.8 2399.3,1033.8"];
	" activity "	[height=0.5,
		pos="2574.5,1074.4",
		width=1.1735];
	" extra protein antagonists " -> " activity "	[label=" display ",
		lp="2510.1,1066.6",
		pos="e,2542.6,1062.5 2533.5,1059.1 2533.6,1059.1 2533.7,1059.1 2533.8,1059.2"];
	" course leading survival .12 translocation "	[height=0.5,
		pos="2411.5,1107.1",
		width=4.4232];
	" expression " -> " course leading survival .12 translocation "	[label=" link ",
		lp="2383.9,1057.6",
		pos="e,2405.9,1089 2393.9,1050.7 2396.6,1059.4 2399.9,1069.9 2402.9,1079.5"];
	" aggressive course leading survival .12 translocation "	[height=0.5,
		pos="2338.1,1015",
		width=5.5065];
	" expression " -> " aggressive course leading survival .12 translocation "	[label=" link ",
		lp="2365.7,1012.1",
		pos="e,2351,1019.6 2351.3,1019.7 2351.2,1019.7 2351.2,1019.6 2351.1,1019.6"];
	" aggressive course "	[height=0.5,
		pos="2344.4,945.5",
		width=2.1665];
	" expression " -> " aggressive course "	[label=" link ",
		lp="2383.1,986.11",
		pos="e,2353.5,963.56 2379.2,1014.7 2373.1,1002.5 2364.9,986.25 2358,972.55"];
	" aggressive clinical course leading survival .12 translocation "	[height=0.5,
		pos="2432.7,991.9",
		width=6.3008];
	" expression " -> " aggressive clinical course leading survival .12 translocation "	[label=" link ",
		lp="2421.6,1008",
		pos="e,2413.2,1009.8 2406.9,1015.7 2407,1015.5 2407.1,1015.4 2407.3,1015.3"];
	" clinical course leading "	[height=0.5,
		pos="2380.9,942",
		width=2.6359];
	" expression " -> " clinical course leading "	[label=" link ",
		lp="2399.5,984.88",
		pos="e,2382.4,960.03 2386.8,1014.4 2385.8,1001.8 2384.4,984.74 2383.2,970.37"];
	" ras/mapk pathway "	[height=0.5,
		pos="2316.3,1098.8",
		width=2.2387];
	" expression " -> " ras/mapk pathway "	[label=" also trigger growth via ",
		lp="2290.4,1054.5",
		pos="e,2335.6,1081.2 2369.8,1049.8 2361.6,1057.2 2352,1066.1 2343.1,1074.3"];
	" clinical course leading survival .12 translocation "	[height=0.5,
		pos="2416.1,951.44",
		width=5.1995];
	" expression " -> " clinical course leading survival .12 translocation "	[label=" link ",
		lp="2415,989.46",
		pos="e,2410,969.44 2394.5,1014.7 2398,1004.3 2402.6,990.95 2406.6,979.22"];
	" course "	[height=0.5,
		pos="2323.4,976.26",
		width=1.0652];
	" expression " -> " course "	[label=" link ",
		lp="2344.8,1015",
		pos="e,2341.9,992.42 2368.8,1015.8 2362.8,1010.6 2356.1,1004.8 2349.8,999.22"];
	" bone-forming osteoblasts "	[height=0.5,
		pos="2654,1067.9",
		width=2.9247];
	" activity " -> " bone-forming osteoblasts "	[label=" formation ",
		lp="2585.2,1078.4",
		pos="e,2616.6,1070.9 2616.1,1071 2616.2,1070.9 2616.3,1070.9 2616.3,1070.9"];
	" osteoblasts "	[height=0.5,
		pos="2643.6,1117",
		width=1.4985];
	" activity " -> " osteoblasts "	[label=" formation ",
		lp="2634.9,1100",
		pos="e,2617.9,1101.1 2598.7,1089.3 2602.1,1091.4 2605.6,1093.6 2609.2,1095.7"];
	" translation.myc inhibition "	[height=0.5,
		pos="2614.6,1154.5",
		width=2.9789];
	" activity " -> " translation.myc inhibition "	[label=" upregulates ",
		lp="2557.2,1117.2",
		pos="e,2605.6,1136.5 2583.4,1092.2 2588.6,1102.5 2595.2,1115.7 2601,1127.3"];
	" binding brd motifs "	[height=0.5,
		pos="2640.9,1020.7",
		width=2.2748];
	" activity " -> " binding brd motifs "	[label=" act ",
		lp="2614.7,1044",
		pos="e,2619.1,1038.3 2594.4,1058.2 2599.7,1054 2605.4,1049.4 2611.1,1044.8"];
	" cell sensitivity lenalidomide "	[height=0.5,
		pos="2609.6,991.16",
		width=3.2136];
	" activity " -> " cell sensitivity lenalidomide "	[label=" independent ",
		lp="2627.1,1045",
		pos="e,2602,1009.2 2582.1,1056.3 2586.8,1045.3 2592.8,1031 2598,1018.6"];
	" myc downregulation .131 "	[height=0.5,
		pos="2573.4,1158.4",
		width=2.9608];
	" activity " -> " myc downregulation .131 "	[label=" involve ",
		lp="2574,1103.8",
		pos="e,2573.6,1140.2 2574.3,1092.6 2574.1,1103.5 2573.9,1117.6 2573.8,1129.9"];
	" protein antagonists "	[height=0.5,
		pos="1511.1,2882.5",
		width=2.2929];
	" anti-myeloma activity "	[height=0.5,
		pos="1555.1,2825.2",
		width=2.6178];
	" protein antagonists " -> " anti-myeloma activity "	[label=" display ",
		lp="1506.4,2850.4",
		pos="e,1541.3,2843.2 1524.8,2864.7 1528,2860.4 1531.6,2855.7 1535.1,2851.2"];
	" cell sensitivity "	[height=0.5,
		pos="1579.2,2757",
		width=1.8596];
	" anti-myeloma activity " -> " cell sensitivity "	[label=" independent ",
		lp="1528.5,2788.3",
		pos="e,1572.7,2775.3 1561.6,2806.9 1564,2800.1 1566.7,2792.2 1569.4,2784.8"];
	" terminal protein antagonists "	[height=0.5,
		pos="2862.9,1810.6",
		width=3.1775];
	" promising activity "	[height=0.5,
		pos="2934.1,1800",
		width=2.2387];
	" terminal protein antagonists " -> " promising activity "	[label=" display ",
		lp="2910.6,1807.5",
		pos="e,2934.1,1800 2934.1,1800 2934.1,1800 2934.1,1800 2934.1,1800"];
	" bromodomain "	[height=0.5,
		pos="801.94,2816.5",
		width=1.8234];
	" expression myc "	[height=0.5,
		pos="845.96,2759.2",
		width=1.9859];
	" bromodomain " -> " expression myc "	[label=" decrease ",
		lp="793.31,2784.4",
		pos="e,832.13,2777.2 815.63,2798.7 818.91,2794.4 822.48,2789.7 825.98,2785.2"];
	" extra terminal protein antagonists "	[height=0.5,
		pos="870.07,2691",
		width=3.7372];
	" extra terminal protein antagonists " -> " expression myc "	[label=" decrease ",
		lp="832.19,2727.8",
		pos="e,852.44,2740.8 863.61,2709.3 861.2,2716.1 858.42,2723.9 855.78,2731.4"];
	" better understanding "	[height=0.5,
		pos="785.18,1249.2",
		width=2.4373];
	" development patients.multiple myeloma "	[height=0.5,
		pos="843.7,1308.3",
		width=4.4232];
	" better understanding " -> " development patients.multiple myeloma "	[label=" inform ",
		lp="833.69,1282.5",
		pos="e,825.75,1290.2 802.74,1267 807.74,1272 813.28,1277.6 818.64,1283"];
	" development precision therapy patients.multiple myeloma "	[height=0.5,
		pos="727.46,1189.8",
		width=6.1925];
	" better understanding " -> " development precision therapy patients.multiple myeloma "	[label=" inform ",
		lp="737.02,1215.8",
		pos="e,745.17,1208 767.86,1231.4 762.93,1226.3 757.46,1220.7 752.18,1215.2"];
	" patients.multiple myeloma "	[height=0.5,
		pos="725.7,1306.5",
		width=3.0872];
	" better understanding " -> " patients.multiple myeloma "	[label=" development ",
		lp="719.66,1281.8",
		pos="e,744.39,1288.5 766.69,1267.1 761.92,1271.7 756.7,1276.7 751.64,1281.6"];
	" development "	[height=0.5,
		pos="849.17,1185.8",
		width=1.7151];
	" better understanding " -> " development "	[label=" inform ",
		lp="790.53,1213.6",
		pos="e,831.44,1203.3 803.01,1231.6 809.52,1225.1 817.03,1217.7 824.06,1210.7"];
	" development precision therapy "	[height=0.5,
		pos="787.07,1333.5",
		width=3.4664];
	" better understanding " -> " development precision therapy "	[label=" inform ",
		lp="786.01,1278.7",
		pos="e,786.66,1315.3 785.59,1267.5 785.84,1278.5 786.15,1292.6 786.43,1305"];
	" precision therapy "	[height=0.5,
		pos="700.59,1244.7",
		width=2.1304];
	" better understanding " -> " precision therapy "	[label=" development ",
		lp="661.14,1252.2",
		pos="e,700.6,1244.7 700.65,1244.7 700.64,1244.7 700.63,1244.7 700.62,1244.7"];
	" promise future precision "	[height=0.5,
		pos="922.87,1228.4",
		width=2.8525];
	" development " -> " promise future precision "	[label=" offer ",
		lp="863.64,1211.5",
		pos="e,893,1211.1 877.03,1201.9 879.4,1203.2 881.82,1204.6 884.24,1206.1"];
	" promise future "	[height=0.5,
		pos="805.32,1112.5",
		width=1.8776];
	" development " -> " promise future "	[label=" offer ",
		lp="812.79,1145.9",
		pos="e,816.04,1130.4 838.33,1167.7 833.18,1159.1 826.92,1148.6 821.25,1139.1"];
	" promise future precision mm "	[height=0.5,
		pos="926.63,1158.9",
		width=3.3219];
	" development " -> " promise future precision mm "	[label=" offer ",
		lp="906.37,1179.3",
		pos="e,889.71,1171.7 889.26,1171.9 889.34,1171.8 889.41,1171.8 889.49,1171.8"];
	" promise "	[height=0.5,
		pos="873.18,1107",
		width=1.2277];
	" development " -> " promise "	[label=" offer ",
		lp="876.73,1143.6",
		pos="e,867.73,1124.9 854.74,1167.5 857.7,1157.8 861.4,1145.6 864.71,1134.8"];
	" plasma cells "	[height=0.5,
		pos="2270.5,2282.9",
		width=1.661];
	" increasing levels aberrations "	[height=0.5,
		pos="2322.4,2214.4",
		width=3.2317];
	" plasma cells " -> " increasing levels aberrations "	[label=" acquire ",
		lp="2317.1,2245.5",
		pos="e,2308.5,2232.7 2283.9,2265.2 2289.5,2257.8 2296.1,2249 2302.3,2240.9"];
	" increasing levels "	[height=0.5,
		pos="2208.3,2228.3",
		width=2.0762];
	" plasma cells " -> " increasing levels "	[label=" acquire ",
		lp="2267.5,2251.7",
		pos="e,2228.5,2246 2250.8,2265.6 2246.1,2261.5 2241.1,2257.1 2236.1,2252.7"];
	" increasing levels genetic aberrations "	[height=0.5,
		pos="2220.5,2347.4",
		width=3.9899];
	" plasma cells " -> " increasing levels genetic aberrations "	[label=" acquire ",
		lp="2272.7,2303.4",
		pos="e,2234.5,2329.3 2256.8,2300.5 2251.8,2306.9 2246.1,2314.3 2240.6,2321.4"];
	" increasing levels aberrations including copy number variations "	[height=0.5,
		pos="2340.3,2328.2",
		width=6.6077];
	" plasma cells " -> " increasing levels aberrations including copy number variations "	[label=" acquire ",
		lp="2323.9,2309.4",
		pos="e,2312.5,2310.1 2295.7,2299.2 2298.4,2301 2301.3,2302.8 2304.1,2304.7"];
	" increasing levels genetic aberrations including copy number variations "	[height=0.5,
		pos="2288.4,2364.9",
		width=7.3841];
	" plasma cells " -> " increasing levels genetic aberrations including copy number variations "	[label=" acquire ",
		lp="2254.4,2311.5",
		pos="e,2284.4,2346.7 2274.5,2301.1 2276.8,2311.6 2279.7,2325 2282.3,2336.8"];
	" levels "	[height=0.5,
		pos="2186.1,2286.8",
		width=1.011];
	" plasma cells " -> " levels "	[label=" acquire ",
		lp="2187.3,2293.1",
		pos="e,2211.1,2285.7 2211.4,2285.6 2211.3,2285.6 2211.3,2285.6 2211.2,2285.6"];
	" clonal plasma cells "	[height=0.5,
		pos="2370.7,2145.2",
		width=2.3109];
	" clonal plasma cells " -> " increasing levels aberrations "	[label=" acquire ",
		lp="2325.5,2183",
		pos="e,2335,2196.4 2358.2,2163 2352.9,2170.6 2346.6,2179.7 2340.8,2188"];
	" levels aberrations "	[height=0.5,
		pos="2377.9,2064",
		width=2.1484];
	" clonal plasma cells " -> " levels aberrations "	[label=" acquire ",
		lp="2349.8,2117.3",
		pos="e,2376.3,2082.2 2372.3,2127.2 2373.2,2116.9 2374.3,2103.9 2375.4,2092.3"];
	" levels genetic aberrations "	[height=0.5,
		pos="2446.9,2182.2",
		width=2.9247];
	" clonal plasma cells " -> " levels genetic aberrations "	[label=" acquire ",
		lp="2381,2154.3",
		pos="e,2411.5,2165 2404.8,2161.7 2404.9,2161.8 2405.1,2161.9 2405.2,2161.9"];
	" levels aberrations including copy number variations "	[height=0.5,
		pos="2443.6,2109.7",
		width=5.5426];
	" clonal plasma cells " -> " levels aberrations including copy number variations "	[label=" acquire ",
		lp="2380.7,2136.1",
		pos="e,2406.8,2127.6 2404.6,2128.7 2404.7,2128.7 2404.8,2128.6 2404.9,2128.6"];
	" levels genetic aberrations including copy number variations "	[height=0.5,
		pos="2310.2,2085.9",
		width=6.3189];
	" clonal plasma cells " -> " levels genetic aberrations including copy number variations "	[label=" acquire ",
		lp="2320.3,2126.8",
		pos="e,2328.7,2104.1 2352.5,2127.4 2347.4,2122.3 2341.6,2116.7 2336.1,2111.3"];
	" guidelines "	[height=0.5,
		pos="134.2,242.48",
		width=1.4443];
	" disease risk stratification "	[height=0.5,
		pos="178.22,185.15",
		width=2.8525];
	" guidelines " -> " disease risk stratification "	[label=" define ",
		lp="132.35,210.7",
		pos="e,164.25,203.35 147.65,224.97 150.93,220.69 154.52,216.01 158.05,211.42"];
	" clinical guidelines "	[height=0.5,
		pos="202.33,117",
		width=2.2206];
	" clinical guidelines " -> " disease risk stratification "	[label=" define ",
		lp="171.45,153.83",
		pos="e,184.7,166.84 195.87,135.26 193.46,142.06 190.68,149.94 188.04,157.4"];
	" h-mm "	[height=0.5,
		pos="1850.2,185.21",
		width=1.0471];
	" trisomies "	[height=0.5,
		pos="1894.1,242.63",
		width=1.336];
	" h-mm " -> " trisomies "	[label=" characterize ",
		lp="1832.3,217.06",
		pos="e,1880.8,225.23 1863.2,202.12 1866.7,206.79 1870.7,211.95 1874.5,216.99"];
	" trisomies chromosomes "	[height=0.5,
		pos="1826.3,117",
		width=2.7984];
	" h-mm " -> " trisomies chromosomes "	[label=" characterize ",
		lp="1803.5,148.48",
		pos="e,1832.6,135.04 1843.9,167.29 1841.5,160.37 1838.7,152.3 1836,144.67"];
	" harbor igh translocations "	[height=0.5,
		pos="706.87,127.64",
		width=2.8706];
	" tumor progression "	[height=0.5,
		pos="778.08,117",
		width=2.2387];
	" harbor igh translocations " -> " tumor progression "	[label=" contribute ",
		lp="746.54,124.51",
		pos="e,778.07,117 778.03,117.01 778.04,117.01 778.05,117.01 778.05,117"];
	" nh-mm harbor igh translocations "	[height=0.5,
		pos="2715.5,127.64",
		width=3.665];
	" myc rearrangements "	[height=0.5,
		pos="2786.7,117",
		width=2.4553];
	" nh-mm harbor igh translocations " -> " myc rearrangements "	[label=" include ",
		lp="2762.6,124.51",
		pos="e,2786.7,117 2786.6,117.01 2786.6,117.01 2786.6,117.01 2786.6,117"];
	" risk category "	[height=0.5,
		pos="2183.3,2849.5",
		width=1.7151];
	" 1q gain "	[height=0.5,
		pos="2227.3,2792.2",
		width=1.1735];
	" risk category " -> " 1q gain "	[label=" include ",
		lp="2178.3,2817.2",
		pos="e,2214.1,2809.4 2197,2831.7 2200.4,2827.2 2204.1,2822.4 2207.7,2817.6"];
	" intermediate risk category "	[height=0.5,
		pos="2251.4,2724",
		width=3.015];
	" intermediate risk category " -> " 1q gain "	[label=" include ",
		lp="2217,2761",
		pos="e,2233.6,2774.3 2244.9,2742.3 2242.5,2749.2 2239.7,2757.2 2237,2764.8"];
	" chromosomal abnormalities "	[height=0.5,
		pos="2432.6,1661.6",
		width=3.1955];
	" cd138 lactate dehydrogenase sorting mm "	[height=0.5,
		pos="2474.8,1591.7",
		width=4.4774];
	" chromosomal abnormalities " -> " cd138 lactate dehydrogenase sorting mm "	[label=" detect ",
		lp="2431,1638.6",
		pos="e,2463.8,1609.9 2443.5,1643.6 2448.1,1636 2453.5,1627 2458.6,1618.6"];
	" cd138 lactate dehydrogenase sorting "	[height=0.5,
		pos="2364.8,1614.6",
		width=4.008];
	" chromosomal abnormalities " -> " cd138 lactate dehydrogenase sorting "	[label=" detect ",
		lp="2382.9,1633.5",
		pos="e,2390.5,1632.4 2407,1643.8 2404.3,1642 2401.5,1640 2398.8,1638.1"];
	" cd138 lactate dehydrogenase "	[height=0.5,
		pos="2359.7,1697.6",
		width=3.2678];
	" chromosomal abnormalities " -> " cd138 lactate dehydrogenase "	[label=" detect ",
		lp="2377.7,1686.4",
		pos="e,2394.8,1680.3 2397.9,1678.8 2397.8,1678.8 2397.6,1678.9 2397.5,1679"];
	" i-fish "	[height=0.5,
		pos="2506.1,1699.2",
		width=0.93881];
	" chromosomal abnormalities " -> " i-fish "	[label=" detect ",
		lp="2449.5,1688",
		pos="e,2481.6,1686.7 2466.3,1678.9 2468.4,1679.9 2470.5,1681 2472.6,1682.1"];
	" cd138 lactate dehydrogenase sorting diagnosed mm "	[height=0.5,
		pos="2435.5,1743",
		width=5.5426];
	" chromosomal abnormalities " -> " cd138 lactate dehydrogenase sorting diagnosed mm "	[label=" detect ",
		lp="2413.9,1704.7",
		pos="e,2434.8,1725 2433.3,1679.6 2433.6,1690 2434.1,1703.2 2434.5,1714.8"];
	" risk patients "	[height=0.5,
		pos="2748.9,282.66",
		width=1.6249];
	" revised staging system "	[height=0.5,
		pos="2815.6,239.42",
		width=2.672];
	" risk patients " -> " revised staging system "	[label=" propose ",
		lp="2751.5,256.92",
		pos="e,2788.5,256.94 2774.1,266.31 2776,265.07 2778,263.8 2779.9,262.52"];
	" revised staging system named "	[height=0.5,
		pos="2705.7,216",
		width=3.3941];
	" risk patients " -> " revised staging system named "	[label=" propose ",
		lp="2704.7,261.28",
		pos="e,2717.6,234.38 2737.3,264.79 2732.9,258.03 2727.8,250.18 2723.1,242.77"];
	" mutations .4,5 "	[height=0.5,
		pos="2682.7,326.51",
		width=1.8596];
	" risk patients " -> " mutations .4,5 "	[label=" carry ",
		lp="2738.3,309.08",
		pos="e,2708,309.73 2724.2,298.99 2721.7,300.68 2719,302.43 2716.4,304.18"];
	" staging system "	[height=0.5,
		pos="2792.7,348.97",
		width=1.8957];
	" risk patients " -> " staging system "	[label=" propose ",
		lp="2793.5,319.06",
		pos="e,2780.9,331.15 2760.6,300.43 2765.2,307.27 2770.4,315.23 2775.4,322.7"];
	" abnormalities "	[height=0.5,
		pos="2510.1,1524.8",
		width=1.7693];
	" abnormalities " -> " cd138 lactate dehydrogenase sorting mm "	[label=" detect ",
		lp="2474.8,1561.2",
		pos="e,2484.3,1573.7 2500.6,1542.7 2497.1,1549.4 2492.9,1557.3 2489,1564.7"];
	" cd138 lactate dehydrogenase sorting newly diagnosed mm "	[height=0.5,
		pos="2559.2,1470",
		width=6.2106];
	" abnormalities " -> " cd138 lactate dehydrogenase sorting newly diagnosed mm "	[label=" detect ",
		lp="2511.1,1493.8",
		pos="e,2543.1,1488 2525.9,1507.1 2529.2,1503.4 2532.8,1499.4 2536.4,1495.4"];
	" standard risk patients "	[height=0.5,
		pos="1057.5,721.64",
		width=2.5276];
	" staging system named "	[height=0.5,
		pos="1128.7,711",
		width=2.6359];
	" standard risk patients " -> " staging system named "	[label=" propose ",
		lp="1103.2,718.51",
		pos="e,1128.7,711 1128.7,711.01 1128.7,711.01 1128.7,711.01 1128.7,711"];
	" msmart risk stratification guidelines "	[height=0.5,
		pos="685.05,1602",
		width=3.9899];
	" biomarkers "	[height=0.5,
		pos="701.12,1672.5",
		width=1.5526];
	" msmart risk stratification guidelines " -> " biomarkers "	[label=" rely however ",
		lp="652.43,1639.7",
		pos="e,696.94,1654.1 689.18,1620.1 690.86,1627.5 692.83,1636.1 694.68,1644.3"];
	" mayo clinic 's msmart risk stratification guidelines "	[height=0.5,
		pos="699.51,1744.7",
		width=5.4162];
	" mayo clinic 's msmart risk stratification guidelines " -> " biomarkers "	[label=" rely ",
		lp="685.7,1706.1",
		pos="e,700.71,1690.7 699.92,1726.5 700.09,1718.7 700.3,1709.4 700.49,1700.8"];
	" i-fish biomarkers "	[height=0.5,
		pos="691.01,1816.3",
		width=2.1123];
	" mayo clinic 's msmart risk stratification guidelines " -> " i-fish biomarkers "	[label=" rely however ",
		lp="656.37,1782.9",
		pos="e,693.19,1798 697.37,1762.8 696.46,1770.4 695.38,1779.5 694.37,1788"];
	" research "	[height=0.5,
		pos="1452.6,430.51",
		width=1.2457];
	" language studies "	[height=0.5,
		pos="1524,389.01",
		width=2.0582];
	" research " -> " language studies "	[label=" clinicaltrials.gov ",
		lp="1531.9,420.69",
		pos="e,1495.1,405.8 1478.3,415.53 1481,414 1483.7,412.42 1486.4,410.84"];
	" english language studies "	[height=0.5,
		pos="1452.4,348",
		width=2.8345];
	" research " -> " english language studies "	[label=" clinicaltrials.gov ",
		lp="1403,401.88",
		pos="e,1452.4,366.26 1452.5,412.2 1452.5,401.73 1452.5,388.37 1452.5,376.55"];
	" aberrant molecular pathways "	[height=0.5,
		pos="1381.8,472.96",
		width=3.2858];
	" research " -> " aberrant molecular pathways "	[label=" identify ",
		lp="1398.7,440.36",
		pos="e,1411.2,455.32 1427.4,445.6 1425,447.07 1422.4,448.59 1419.9,450.12"];
	" molecular pathways "	[height=0.5,
		pos="1524.5,471.05",
		width=2.4192];
	" research " -> " molecular pathways "	[label=" identify ",
		lp="1507,439.61",
		pos="e,1494.3,453.99 1479,445.38 1481,446.52 1483,447.68 1485.1,448.85"];
	" pathways "	[height=0.5,
		pos="1454,513.07",
		width=1.354];
	" research " -> " pathways "	[label=" identify ",
		lp="1428.2,474.17",
		pos="e,1453.7,494.8 1452.9,448.83 1453.1,459.31 1453.3,472.67 1453.5,484.5"];
	" aberrant pathways "	[height=0.5,
		pos="1380.8,389.9",
		width=2.2206];
	" research " -> " aberrant pathways "	[label=" identify ",
		lp="1397.8,421.18",
		pos="e,1410.5,406.71 1426.2,415.62 1424,414.35 1421.7,413.05 1419.4,411.75"];
	" ourwe "	[height=0.5,
		pos="1136.2,1117.6",
		width=1.0471];
	" pubmed "	[height=0.5,
		pos="1207.4,1107",
		width=1.2277];
	" ourwe " -> " pubmed "	[label=" search ",
		lp="1193.9,1119.7",
		pos="e,1172.7,1112.2 1172.2,1112.3 1172.3,1112.2 1172.4,1112.2 1172.5,1112.2"];
	" search "	[height=0.5,
		pos="212.88,588.08",
		width=1.0652];
	" 03/16/2018 "	[height=0.5,
		pos="286.04,619.08",
		width=1.5526];
	" search " -> " 03/16/2018 "	[label=" perform ",
		lp="268.04,592.93",
		pos="e,252.15,604.72 241.38,600.15 241.82,600.34 242.26,600.53 242.7,600.72"];
	" final search "	[height=0.5,
		pos="317.1,546",
		width=1.5526];
	" final search " -> " 03/16/2018 "	[label=" perform ",
		lp="277.5,570.51",
		pos="e,293.63,601.22 309.42,564.06 305.85,572.47 301.53,582.65 297.57,591.95"];
	" updated search "	[height=0.5,
		pos="254.37,692",
		width=1.8957];
	" updated search " -> " 03/16/2018 "	[label=" perform ",
		lp="242.2,652.67",
		pos="e,278.19,637.15 262.2,673.98 265.81,665.65 270.19,655.58 274.2,646.35"];
	" final updated search "	[height=0.5,
		pos="358.82,650.9",
		width=2.4012];
	" final updated search " -> " 03/16/2018 "	[label=" perform ",
		lp="347.45,627.06",
		pos="e,319.49,633.7 321.58,634.62 321.49,634.58 321.41,634.54 321.32,634.5"];
	" relevant articles "	[height=0.5,
		pos="1902.1,2196",
		width=1.9859];
	" preclinical studies "	[height=0.5,
		pos="1901.9,2275.3",
		width=2.2026];
	" relevant articles " -> " preclinical studies "	[label=" yield ",
		lp="1884.5,2238",
		pos="e,1902,2257.1 1902.1,2214 1902,2223.8 1902,2236.1 1902,2247.1"];
	" articles "	[height=0.5,
		pos="1849.9,2339.4",
		width=1.1374];
	" articles " -> " preclinical studies "	[label=" yield ",
		lp="1854.8,2304.3",
		pos="e,1887.2,2293.4 1863.8,2322.2 1869,2315.8 1875,2308.4 1880.7,2301.4"];
	" studies "	[height=0.5,
		pos="1768.3,2359.5",
		width=1.1193];
	" articles " -> " studies "	[label=" yield ",
		lp="1831.2,2355.8",
		pos="e,1803.8,2350.8 1813.9,2348.3 1813.8,2348.3 1813.7,2348.3 1813.6,2348.4"];
	" case reports "	[height=0.5,
		pos="1901.1,2403.4",
		width=1.6068];
	" articles " -> " case reports "	[label=" yield ",
		lp="1854.6,2374.6",
		pos="e,1887,2385.7 1863.6,2356.6 1868.8,2363 1874.8,2370.6 1880.5,2377.7"];
	" response "	[height=0.5,
		pos="937.78,2424.6",
		width=1.2818];
	" patients "	[height=0.5,
		pos="896.61,2510.5",
		width=1.1916];
	" response " -> " patients "	[label=" see ",
		lp="931.91,2455.5",
		pos="e,905.13,2492.8 929.25,2442.4 923.57,2454.3 915.98,2470.1 909.56,2483.5"];
	" translocation "	[height=0.5,
		pos="1022.2,2397",
		width=1.6971];
	" response " -> " translocation "	[label=" see ",
		lp="986.31,2420.3",
		pos="e,981.17,2410.4 973.57,2412.9 973.73,2412.9 973.89,2412.8 974.04,2412.8"];
	" 9.7 months "	[height=0.5,
		pos="874.9,2447.8",
		width=1.5526];
	" response " -> " 9.7 months "	[label=" duration ",
		lp="877.54,2429.6",
		pos="e,903.78,2437.2 904.13,2437 904.07,2437 904.01,2437.1 903.96,2437.1"];
	" best response "	[height=0.5,
		pos="1101.6,2422.1",
		width=1.7512];
	" best response " -> " translocation "	[label=" see ",
		lp="1046.5,2416.1",
		pos="e,1058.6,2408.5 1059.1,2408.7 1059,2408.6 1058.9,2408.6 1058.9,2408.6"];
	" treatment "	[height=0.5,
		pos="1419,2504.2",
		width=1.3721];
	" events "	[height=0.5,
		pos="1497.8,2498.9",
		width=1.0652];
	" treatment " -> " events "	[label=" consider ",
		lp="1494.6,2508.4",
		pos="e,1467.9,2500.9 1467.5,2500.9 1467.6,2500.9 1467.6,2500.9 1467.7,2500.9"];
	" adverse events "	[height=0.5,
		pos="1401.9,2427",
		width=1.8776];
	" treatment " -> " adverse events "	[label=" consider ",
		lp="1384.5,2478",
		pos="e,1405.9,2445.2 1414.9,2485.9 1412.9,2476.7 1410.4,2465.3 1408.1,2455"];
	" orr "	[height=0.5,
		pos="1710.5,1573.3",
		width=0.75];
	" steroid "	[height=0.5,
		pos="1679.7,1494.7",
		width=1.1013];
	" orr " -> " steroid "	[label=" inhibitor ",
		lp="1669.5,1546.5",
		pos="e,1686.7,1512.7 1703.6,1555.9 1699.7,1545.9 1694.8,1533.3 1690.4,1522"];
	" ras/raf/mek "	[height=0.5,
		pos="348.3,2130",
		width=1.5526];
	" gene expression "	[height=0.5,
		pos="364.38,2200.5",
		width=2.004];
	" ras/raf/mek " -> " gene expression "	[label=" regulator ",
		lp="326.69,2167.7",
		pos="e,360.2,2182.1 352.44,2148.1 354.12,2155.5 356.09,2164.1 357.94,2172.3"];
	" chromatin state "	[height=0.5,
		pos="362.77,2272.7",
		width=1.9498];
	" gene expression " -> " chromatin state "	[label=" change ",
		lp="340.69,2239",
		pos="e,363.18,2254.5 363.97,2218.7 363.8,2226.5 363.59,2235.7 363.4,2244.4"];
	" increased expression "	[height=0.5,
		pos="2236.5,1152.8",
		width=2.4734];
	" increased expression " -> " ras/mapk pathway "	[label=" trigger growth via ",
		lp="2325.3,1136.1",
		pos="e,2290.9,1116 2262.2,1135.5 2268.7,1131.1 2275.7,1126.3 2282.5,1121.7"];
	" course leading "	[height=0.5,
		pos="2151.8,1166.9",
		width=1.8596];
	" increased expression " -> " course leading "	[label=" link ",
		lp="2152.7,1156.8",
		pos="e,2166.9,1164.4 2167.3,1164.3 2167.2,1164.3 2167.2,1164.4 2167.1,1164.4"];
	" aggressive clinical course leading "	[height=0.5,
		pos="2182.6,1114.8",
		width=3.7372];
	" increased expression " -> " aggressive clinical course leading "	[label=" link ",
		lp="2197,1127.7",
		pos="e,2207.8,1132.6 2211.8,1135.4 2211.6,1135.3 2211.4,1135.2 2211.3,1135"];
	" aggressive clinical course leading shorter survival .12 translocation "	[height=0.5,
		pos="2144,1123",
		width=7.041];
	" increased expression " -> " aggressive clinical course leading shorter survival .12 translocation "	[label=" link ",
		lp="2174.6,1130",
		pos="e,2188.9,1137.5 2189.2,1137.6 2189.1,1137.5 2189.1,1137.5 2189,1137.5"];
	" aggressive clinical course "	[height=0.5,
		pos="2292.5,1224.8",
		width=2.9608];
	" increased expression " -> " aggressive clinical course "	[label=" link ",
		lp="2246.9,1192.4",
		pos="e,2278.5,1206.9 2250.6,1171 2257.2,1179.4 2265.1,1189.5 2272.2,1198.8"];
	" growth "	[height=0.5,
		pos="2214.1,1254.6",
		width=1.1193];
	" increased expression " -> " growth "	[label=" trigger ",
		lp="2204.3,1206.4",
		pos="e,2218.1,1236.6 2232.5,1171 2229.1,1186.5 2224.1,1209 2220.2,1226.8"];
	" aggressive course leading "	[height=0.5,
		pos="2247.4,1213.8",
		width=2.9608];
	" increased expression " -> " aggressive course leading "	[label=" link ",
		lp="2255.6,1170.9",
		pos="e,2244.1,1195.5 2239.8,1171.1 2240.6,1175.7 2241.5,1180.7 2242.4,1185.6"];
	" aggressive course leading shorter survival .12 translocation "	[height=0.5,
		pos="2220.7,1084.7",
		width=6.2647];
	" increased expression " -> " aggressive course leading shorter survival .12 translocation "	[label=" link ",
		lp="2215.2,1131.3",
		pos="e,2225,1103 2232.2,1134.6 2230.7,1127.9 2228.9,1120.3 2227.3,1113"];
	" clinical course leading shorter survival .12 translocation "	[height=0.5,
		pos="2294.8,1185.2",
		width=5.9398];
	" increased expression " -> " clinical course leading shorter survival .12 translocation "	[label=" link ",
		lp="2281.6,1177.3",
		pos="e,2267.3,1169.9 2267,1169.8 2267.1,1169.8 2267.1,1169.8 2267.2,1169.8"];
	" course leading shorter survival .12 translocation "	[height=0.5,
		pos="2181.9,1195.7",
		width=5.1634];
	" increased expression " -> " course leading shorter survival .12 translocation "	[label=" link ",
		lp="2227.9,1178.5",
		pos="e,2204.7,1177.8 2213.9,1170.5 2213.6,1170.8 2213.2,1171.1 2212.8,1171.4"];
	" clinical course "	[height=0.5,
		pos="2174.9,1075.2",
		width=1.8596];
	" increased expression " -> " clinical course "	[label=" link ",
		lp="2194.3,1110.4",
		pos="e,2188.9,1092.8 2222.2,1134.8 2214.2,1124.8 2204.1,1112 2195.3,1100.9"];
	" ras/raf/mek erk signaling "	[height=0.5,
		pos="2192.5,1330.2",
		width=2.9067];
	" growth " -> " ras/raf/mek erk signaling "	[label=" identify ",
		lp="2229.7,1294.9",
		pos="e,2197.7,1312.2 2209,1272.5 2206.4,1281.4 2203.3,1292.3 2200.5,1302.3"];
	" target "	[height=0.5,
		pos="2260.9,1330.9",
		width=0.99297];
	" growth " -> " target "	[label=" identify ras/raf/mek erk signal ",
		lp="2278.2,1281.2",
		pos="e,2250.3,1313.6 2225,1272.3 2230.9,1282 2238.4,1294.2 2245,1305"];
	" therapeutic target "	[height=0.5,
		pos="2131.6,1284.9",
		width=2.1484];
	" growth " -> " therapeutic target "	[label=" identify ras/raf/mek erk signal ",
		lp="2096.3,1258.6",
		pos="e,2173.1,1269.7 2182.9,1266.1 2182.8,1266.1 2182.7,1266.1 2182.6,1266.2"];
	" linked "	[height=0.5,
		pos="2430,1077.3",
		width=1.0471];
	" linked " -> " expression "	[label=" cause ",
		lp="2431.9,1051.6",
		pos="e,2404.5,1050.1 2414.5,1060.7 2413.5,1059.6 2412.4,1058.5 2411.4,1057.4"];
	" rrmm patients "	[height=0.5,
		pos="123.68,2858.2",
		width=1.8234];
	" comparison ndmm "	[height=0.5,
		pos="167.58,2915.6",
		width=2.3109];
	" rrmm patients " -> " comparison ndmm "	[label=" incidence ",
		lp="112.49,2890.3",
		pos="e,153.79,2897.6 137.33,2876.1 140.6,2880.3 144.16,2885 147.65,2889.6"];
	" comparison "	[height=0.5,
		pos="99.725,2790",
		width=1.5887];
	" rrmm patients " -> " comparison "	[label=" incidence ",
		lp="83.416,2821.5",
		pos="e,106.06,2808 117.39,2840.3 114.96,2833.4 112.12,2825.3 109.44,2817.7"];
	" response rates "	[height=0.5,
		pos="1378.6,2718.2",
		width=1.8234];
	" treatment bortezomib monotherapy "	[height=0.5,
		pos="1378.7,2644",
		width=3.9358];
	" response rates " -> " treatment bortezomib monotherapy "	[label=" time follow ",
		lp="1342.6,2678.5",
		pos="e,1378.6,2662.2 1378.6,2699.9 1378.6,2691.5 1378.6,2681.5 1378.6,2672.2"];
	" lower response rates "	[height=0.5,
		pos="1366.3,2566.2",
		width=2.4373];
	" lower response rates " -> " treatment "	[label=" shorter time follow ",
		lp="1446.1,2531.3",
		pos="e,1404.3,2521.5 1381.5,2548.3 1386.5,2542.4 1392.3,2535.6 1397.7,2529.3"];
	" lower response rates " -> " treatment bortezomib monotherapy "	[label=" shorter time follow ",
		lp="1315.1,2607.5",
		pos="e,1375.7,2625.8 1369.1,2584.3 1370.6,2593.6 1372.5,2605.3 1374.2,2615.8"];
	" progression "	[height=0.5,
		pos="1287.1,2553.4",
		width=1.5707];
	" lower response rates " -> " progression "	[label=" shorter time ",
		lp="1334,2547.5",
		pos="e,1296.8,2555 1297.1,2555 1297.1,2555 1297,2555 1297,2555"];
	" mek inhibitors "	[height=0.5,
		pos="1221.3,1624.5",
		width=1.8776];
	" mm cell lines "	[height=0.5,
		pos="1140.3,1603.8",
		width=1.7873];
	" mek inhibitors " -> " mm cell lines "	[label=" kill ",
		lp="1159.2,1619.4",
		pos="e,1171.9,1611.9 1172.3,1612 1172.2,1612 1172.2,1611.9 1172.1,1611.9"];
	" mm cell lines " -> " inhibition "	[label=" bet ",
		lp="1120.4,1567.3",
		pos="e,1126.9,1523.6 1137.2,1585.7 1134.8,1571.3 1131.4,1550.7 1128.6,1534"];
	" azd6244 "	[height=0.5,
		pos="1323.5,1245.4",
		width=1.2638];
	" improvement "	[height=0.5,
		pos="1243.2,1277.1",
		width=1.7693];
	" azd6244 " -> " improvement "	[label=" result ",
		lp="1271.3,1251",
		pos="e,1280.3,1262.5 1290.8,1258.3 1290.5,1258.4 1290.2,1258.6 1289.8,1258.7"];
	" phase "	[height=0.5,
		pos="1376,1182.2",
		width=0.99297];
	" azd6244 " -> " phase "	[label=" result ",
		lp="1365.6,1210.1",
		pos="e,1362,1199.1 1337.8,1228.2 1343.3,1221.6 1349.5,1214.1 1355.4,1207"];
	" combined inhibition "	[height=0.5,
		pos="1221.3,1357.7",
		width=2.4192];
	" improvement " -> " combined inhibition "	[label=" study ",
		lp="1215.1,1320",
		pos="e,1226.2,1339.5 1238.2,1295.4 1235.5,1305.5 1232,1318.2 1228.9,1329.6"];
	" inhibition braf "	[height=0.5,
		pos="1169,1223.5",
		width=1.8415];
	" improvement " -> " inhibition braf "	[label=" study ",
		lp="1228.8,1245.9",
		pos="e,1192.6,1240.6 1219.7,1260.2 1213.8,1255.9 1207.3,1251.2 1201,1246.6"];
	" combined inhibition braf "	[height=0.5,
		pos="1214.5,1207.2",
		width=2.8886];
	" improvement " -> " combined inhibition braf "	[label=" study ",
		lp="1212.3,1254.4",
		pos="e,1221.9,1225.4 1235.8,1259.1 1232.7,1251.7 1229.1,1242.9 1225.7,1234.7"];
	" trials aimed "	[height=0.5,
		pos="1340.8,1104.6",
		width=1.6068];
	" phase " -> " trials aimed "	[label=" ii ",
		lp="1352.6,1155.7",
		pos="e,1349,1122.7 1368,1164.6 1363.6,1154.9 1358.1,1142.7 1353.1,1131.8"];
	" trials "	[height=0.5,
		pos="1455.4,1166.3",
		width=0.92075];
	" phase " -> " trials "	[label=" ii ",
		lp="1419.6,1182.6",
		pos="e,1424.1,1172.6 1409.2,1175.6 1410.8,1175.3 1412.3,1175 1413.9,1174.6"];
	" antimyeloma activity hdac inhibitors preclinical settings "	[height=0.5,
		pos="1522.8,1128.2",
		width=5.9759];
	" trials " -> " antimyeloma activity hdac inhibitors preclinical settings "	[label=" demonstrate ",
		lp="1517.8,1159.8",
		pos="e,1490.9,1146.3 1478.6,1153.2 1479.7,1152.6 1480.9,1151.9 1482,1151.3"];
	" significant improvement "	[height=0.5,
		pos="1178.1,1428.8",
		width=2.8525];
	" significant improvement " -> " inhibition "	[label=" study ",
		lp="1135.1,1470.8",
		pos="e,1136.2,1487.9 1165.2,1447 1158.3,1456.7 1149.6,1468.9 1142,1479.7"];
	" significant improvement " -> " combined inhibition "	[label=" study ",
		lp="1178.4,1390.2",
		pos="e,1210.2,1375.9 1189,1410.9 1193.8,1402.9 1199.6,1393.4 1204.9,1384.6"];
	" mey et al . "	[height=0.5,
		pos="885.39,2345.8",
		width=1.4985];
	" mey et al . " -> " response "	[label=" report ",
		lp="928.92,2388.7",
		pos="e,926.12,2407.1 897.28,2363.7 904.16,2374 912.94,2387.3 920.57,2398.7"];
	" case report rrmm "	[height=0.5,
		pos="805.44,2374.6",
		width=2.1484];
	" mey et al . " -> " case report rrmm "	[label=" report response ",
		lp="802.94,2351.6",
		pos="e,847.71,2359.4 848.69,2359 848.53,2359.1 848.36,2359.1 848.2,2359.2"];
	" case report rrmm v600e mutation "	[height=0.5,
		pos="946.28,2292.4",
		width=3.7552];
	" mey et al . " -> " case report rrmm v600e mutation "	[label=" report response ",
		lp="956.89,2315.5",
		pos="e,925.66,2310.5 904.66,2328.9 908.94,2325.1 913.57,2321.1 918.13,2317.1"];
	" response combination "	[height=0.5,
		pos="804.23,2320.1",
		width=2.5817];
	" mey et al . " -> " response combination "	[label=" report ",
		lp="826.12,2340.9",
		pos="e,845.75,2333.2 846.24,2333.4 846.16,2333.4 846.08,2333.3 845.99,2333.3"];
	" case report "	[height=0.5,
		pos="901.06,2262",
		width=1.4985];
	" mey et al . " -> " case report "	[label=" report response ",
		lp="937.81,2301.3",
		pos="e,897.67,2280.1 888.79,2327.6 890.85,2316.6 893.51,2302.4 895.82,2290"];
	" response combination vemurafenib "	[height=0.5,
		pos="842.92,2274.8",
		width=3.8997];
	" mey et al . " -> " response combination vemurafenib "	[label=" report ",
		lp="886.85,2322.3",
		pos="e,853.78,2293 874.67,2327.9 869.93,2320 864.25,2310.5 859.02,2301.7"];
	" targeted inhibition .31 monoclonal antibodies "	[height=0.5,
		pos="2562.3,1290.8",
		width=4.9107];
	" fgfr domain "	[height=0.5,
		pos="2638.5,1300.3",
		width=1.6068];
	" targeted inhibition .31 monoclonal antibodies " -> " fgfr domain "	[label=" bind ",
		lp="2622.5,1307.8",
		pos="e,2638.5,1300.3 2638.4,1300.3 2638.5,1300.3 2638.5,1300.3 2638.5,1300.3"];
	" underway "	[height=0.5,
		pos="1611.9,1338.7",
		width=1.3902];
	" combination venetoclax atezolizumab patients rrmm .29 fgfr3 inhibition "	[height=0.5,
		pos="1678.6,1295.4",
		width=7.5827];
	" underway " -> " combination venetoclax atezolizumab patients rrmm .29 fgfr3 inhibition "	[label=" use cobimetinib ",
		lp="1686.7,1328.5",
		pos="e,1650.5,1313.6 1636.3,1322.8 1638.2,1321.6 1640.1,1320.3 1642.1,1319.1"];
	" combination venetoclax "	[height=0.5,
		pos="1568.7,1272",
		width=2.7984];
	" underway " -> " combination venetoclax "	[label=" use cobimetinib ",
		lp="1545.6,1317.1",
		pos="e,1580.3,1289.9 1600.3,1320.8 1595.9,1313.9 1590.7,1305.9 1585.8,1298.4"];
	" combination venetoclax atezolizumab "	[height=0.5,
		pos="1545.7,1382.5",
		width=4.1705];
	" underway " -> " combination venetoclax atezolizumab "	[label=" use cobimetinib ",
		lp="1537.1,1349.2",
		pos="e,1572.5,1364.8 1588,1354.5 1585.8,1355.9 1583.5,1357.4 1581.2,1359"];
	" single agent "	[height=0.5,
		pos="1655.7,1405",
		width=1.6068];
	" underway " -> " single agent "	[label=" use cobimetinib ",
		lp="1678.5,1360.1",
		pos="e,1643.9,1387.1 1623.6,1356.4 1628.2,1363.3 1633.4,1371.2 1638.4,1378.7"];
	" combination "	[height=0.5,
		pos="1723.7,1678.9",
		width=1.661];
	" combination " -> " orr "	[label=" show ",
		lp="1736.2,1638.5",
		pos="e,1712.7,1591.5 1721.4,1660.5 1719.3,1644.2 1716.3,1620.2 1714,1601.5"];
	" total 16-week difference .28 "	[height=0.5,
		pos="1737.1,1746.2",
		width=3.2136];
	" combination " -> " total 16-week difference .28 "	[label=" show ",
		lp="1747.9,1715",
		pos="e,1733.5,1728.1 1727.3,1696.9 1728.6,1703.4 1730,1710.9 1731.5,1718.1"];
	" 9.9 months survival "	[height=0.5,
		pos="1776.5,1697.4",
		width=2.4012];
	" combination " -> " 9.9 months survival "	[label=" show ",
		lp="1781.5,1685.1",
		pos="e,1763.3,1692.7 1762.9,1692.6 1763,1692.6 1763.1,1692.7 1763.1,1692.7"];
	" total difference .28 "	[height=0.5,
		pos="1670.5,1689.7",
		width=2.3109];
	" combination " -> " total difference .28 "	[label=" show ",
		lp="1655.4,1681.5",
		pos="e,1673.6,1689.1 1674,1689 1673.9,1689 1673.9,1689 1673.8,1689"];
	" 9.9 months "	[height=0.5,
		pos="1633.5,1635.2",
		width=1.5526];
	" combination " -> " 9.9 months "	[label=" show ",
		lp="1664.6,1666.7",
		pos="e,1664.6,1650.2 1692.1,1663.6 1686.3,1660.8 1680.1,1657.8 1674,1654.8"];
	" 9.9 months progression-free survival "	[height=0.5,
		pos="1788,1656.7",
		width=4.0621];
	" combination " -> " 9.9 months progression-free survival "	[label=" show ",
		lp="1781.9,1672.7",
		pos="e,1763.6,1665.1 1763.3,1665.2 1763.4,1665.2 1763.4,1665.2 1763.5,1665.2"];
	" total "	[height=0.5,
		pos="1693.5,1602.2",
		width=0.86659];
	" combination " -> " total "	[label=" show ",
		lp="1728.9,1652.6",
		pos="e,1700.5,1619.9 1716.5,1660.7 1712.9,1651.4 1708.3,1639.8 1704.2,1629.4"];
	" apoptosis mm cells "	[height=0.5,
		pos="1832.8,1688.5",
		width=2.347];
	" combination " -> " apoptosis mm cells "	[label=" enhance ",
		lp="1807.5,1691.5",
		pos="e,1781.7,1684 1781.4,1684 1781.5,1684 1781.5,1684 1781.6,1684"];
	" median pfs "	[height=0.5,
		pos="1750.5,1589",
		width=1.5346];
	" combination " -> " median pfs "	[label=" improve ",
		lp="1762.6,1631.3",
		pos="e,1745.1,1607.1 1729.1,1660.7 1732.8,1648.2 1737.9,1631.2 1742.1,1617"];
	" double-blind phase iii panorama trial "	[height=0.5,
		pos="1666.7,1649.8",
		width=4.0802];
	" combination " -> " double-blind phase iii panorama trial "	[label=" improve pfs ",
		lp="1656.1,1670.8",
		pos="e,1692.9,1663.2 1693.2,1663.4 1693.2,1663.3 1693.1,1663.3 1693,1663.3"];
	" panorama trial "	[height=0.5,
		pos="1637.2,1741",
		width=1.8776];
	" combination " -> " panorama trial "	[label=" improve pfs ",
		lp="1647.7,1714.4",
		pos="e,1660.8,1724.1 1700.5,1695.6 1690.8,1702.5 1679.4,1710.8 1668.9,1718.3"];
	" phase iii panorama trial "	[height=0.5,
		pos="1775.6,1730",
		width=2.7623];
	" combination " -> " phase iii panorama trial "	[label=" improve pfs ",
		lp="1782.7,1708",
		pos="e,1757.4,1712 1741.3,1696.2 1744.1,1699 1747.1,1701.9 1750.1,1704.8"];
	" pfs "	[height=0.5,
		pos="1763.3,1760.3",
		width=0.75];
	" combination " -> " pfs "	[label=" improve ",
		lp="1768.5,1722.9",
		pos="e,1755,1743.1 1732.5,1697 1737.8,1707.8 1744.6,1721.8 1750.5,1733.9"];
	" % combination doses.77jak-stat inhibition "	[height=0.5,
		pos="1765.3,1634.9",
		width=4.6038];
	" combination " -> " % combination doses.77jak-stat inhibition "	[label=" show cbr ",
		lp="1711.6,1668.5",
		pos="e,1748.1,1653 1740.1,1661.5 1740.5,1661.2 1740.8,1660.8 1741.1,1660.5"];
	" bortezomib patients % combination doses.77jak-stat inhibition "	[height=0.5,
		pos="1779.4,1607.4",
		width=6.6258];
	" combination " -> " bortezomib patients % combination doses.77jak-stat inhibition "	[label=" show orr ",
		lp="1776.2,1654.9",
		pos="e,1765.4,1625.3 1737.4,1661.2 1744,1652.9 1751.9,1642.7 1759,1633.5"];
	" cbr "	[height=0.5,
		pos="1679.6,1730.2",
		width=0.75];
	" combination " -> " cbr "	[label=" show ",
		lp="1722.7,1694.1",
		pos="e,1693.2,1714.4 1708.5,1696.6 1705.7,1699.8 1702.7,1703.3 1699.8,1706.7"];
	" orr % "	[height=0.5,
		pos="1640.4,1689.3",
		width=1.011];
	" combination " -> " orr % "	[label=" show ",
		lp="1649.5,1693.4",
		pos="e,1667.7,1685.9 1668.1,1685.9 1668,1685.9 1668,1685.9 1667.9,1685.9"];
	" cbr % "	[height=0.5,
		pos="1701.4,1751.2",
		width=1.0291];
	" combination " -> " cbr % "	[label=" show ",
		lp="1732.5,1717.9",
		pos="e,1706.9,1733.2 1718,1697.2 1715.6,1705.2 1712.6,1714.8 1709.9,1723.7"];
	" bortezomib refractory patients % combination doses.77jak-stat inhibition "	[height=0.5,
		pos="1725,1620",
		width=7.6549];
	" combination " -> " bortezomib refractory patients % combination doses.77jak-stat inhibition "	[label=" show orr ",
		lp="1696.2,1646.9",
		pos="e,1724.6,1638.1 1724.1,1660.6 1724.2,1656.7 1724.3,1652.5 1724.4,1648.3"];
	" tumor weight "	[height=0.5,
		pos="1665.4,1612.6",
		width=1.7693];
	" combination " -> " tumor weight "	[label=" decrease ",
		lp="1670.4,1642.1",
		pos="e,1680.8,1630.1 1708.4,1661.5 1702,1654.2 1694.5,1645.7 1687.5,1637.8"];
	" 16-week difference .28 "	[height=0.5,
		pos="1570,1579.2",
		width=2.7081];
	" 9.9 months " -> " 16-week difference .28 "	[label=" total ",
		lp="1590,1618.5",
		pos="e,1590.2,1597 1614.1,1618.1 1609,1613.6 1603.4,1608.7 1598,1603.9"];
	" fda approval panobinostat combination bortezomib "	[height=0.5,
		pos="1613.5,1826.8",
		width=5.4703];
	" panorama trial " -> " fda approval panobinostat combination bortezomib "	[label=" result ",
		lp="1607.7,1771.5",
		pos="e,1618.5,1808.7 1632.2,1759.2 1629,1770.7 1624.8,1785.8 1621.2,1798.8"];
	" fda approval panobinostat "	[height=0.5,
		pos="1569.6,1783.4",
		width=2.9789];
	" panorama trial " -> " fda approval panobinostat "	[label=" result ",
		lp="1589.3,1766.7",
		pos="e,1597.4,1765.9 1610.5,1757.8 1609,1758.7 1607.5,1759.6 1606,1760.6"];
	" fda approval panobinostat combination "	[height=0.5,
		pos="1549.6,1720.8",
		width=4.2788];
	" panorama trial " -> " fda approval panobinostat combination "	[label=" result ",
		lp="1566.9,1736.7",
		pos="e,1585.5,1729.1 1586,1729.2 1585.9,1729.2 1585.8,1729.2 1585.8,1729.2"];
	" phase ib/ii trial "	[height=0.5,
		pos="1715.5,1782.3",
		width=1.9137];
	" phase ib/ii trial " -> " combination "	[label=" use cobimetinib ",
		lp="1766.7,1743.2",
		pos="e,1722.2,1697.1 1716.9,1764.3 1718.2,1748.5 1720,1725.4 1721.4,1707.1"];
	" combination venetoclax atezolizumab patients "	[height=0.5,
		pos="1692.9,1865.2",
		width=5.0009];
	" phase ib/ii trial " -> " combination venetoclax atezolizumab patients "	[label=" use cobimetinib ",
		lp="1658.1,1811.3",
		pos="e,1697.9,1847 1710.6,1800.3 1707.6,1811.1 1703.8,1825 1700.5,1837.3"];
	" phase ib/ii clinical trial "	[height=0.5,
		pos="172.37,1406.2",
		width=2.69];
	" agent "	[height=0.5,
		pos="216.27,1463.6",
		width=0.95686];
	" phase ib/ii clinical trial " -> " agent "	[label=" use cobimetinib ",
		lp="144.12,1438.9",
		pos="e,203.38,1446.8 186.02,1424.1 189.57,1428.7 193.45,1433.8 197.22,1438.7"];
	" cobimetinib "	[height=0.5,
		pos="148.41,1338",
		width=1.6068];
	" phase ib/ii clinical trial " -> " cobimetinib "	[label=" use ",
		lp="149.06,1369.4",
		pos="e,154.85,1356.3 165.95,1387.9 163.56,1381.1 160.79,1373.2 158.17,1365.8"];
	" fgfr3 mutations "	[height=0.5,
		pos="2093.7,1911.3",
		width=1.9679];
	" control ig chain promoter "	[height=0.5,
		pos="2179,1881.3",
		width=2.9608];
	" fgfr3 mutations " -> " control ig chain promoter "	[label=" bring fgfr3 ",
		lp="2168.9,1904.1",
		pos="e,2135.6,1896.5 2135.3,1896.6 2135.4,1896.6 2135.4,1896.6 2135.4,1896.6"];
	" fgfs "	[height=0.5,
		pos="2117.7,1985.8",
		width=0.81243];
	" fgfr3 mutations " -> " fgfs "	[label=" compete ",
		lp="2076.6,1951.3",
		pos="e,2111.9,1967.9 2099.5,1929.3 2102.3,1938 2105.7,1948.6 2108.8,1958.3"];
	" control "	[height=0.5,
		pos="2062,1995.9",
		width=1.1193];
	" fgfr3 mutations " -> " control "	[label=" bring fgfr3 ",
		lp="2046.1,1956.2",
		pos="e,2068.7,1978 2086.9,1929.2 2082.7,1940.6 2077.1,1955.4 2072.3,1968.3"];
	" fgfr3 "	[height=0.5,
		pos="2038.5,1846.7",
		width=0.92075];
	" fgfr3 mutations " -> " fgfr3 "	[label=" bring ",
		lp="2050.5,1889.9",
		pos="e,2052.8,1863.4 2078.6,1893.6 2072.7,1886.7 2065.8,1878.6 2059.4,1871.2"];
	" control ig heavy chain promoter "	[height=0.5,
		pos="2166.9,1937.8",
		width=3.6108];
	" fgfr3 mutations " -> " control ig heavy chain promoter "	[label=" bring fgfr3 ",
		lp="2168.2,1918.6",
		pos="e,2135,1926.2 2134.6,1926.1 2134.6,1926.1 2134.7,1926.1 2134.8,1926.1"];
	" targeted inhibition monoclonal antibodies "	[height=0.5,
		pos="2746.7,2041.6",
		width=4.5315];
	" fgfr extracellular domain "	[height=0.5,
		pos="2817.9,2031",
		width=2.9067];
	" targeted inhibition monoclonal antibodies " -> " fgfr extracellular domain "	[label=" bind ",
		lp="2801.8,2038.5",
		pos="e,2817.9,2031 2817.8,2031 2817.8,2031 2817.8,2031 2817.8,2031"];
	" usage "	[height=0.5,
		pos="858.93,282.66",
		width=0.99297];
	" survival 6.2 months "	[height=0.5,
		pos="925.62,239.42",
		width=2.4012];
	" usage " -> " survival 6.2 months "	[label=" show ",
		lp="904.38,272.69",
		pos="e,899.11,256.61 881.13,268.26 884.19,266.28 887.39,264.2 890.62,262.11"];
	" progression-free survival 6.2 months "	[height=0.5,
		pos="815.77,216",
		width=4.0621];
	" usage " -> " progression-free survival 6.2 months "	[label=" show ",
		lp="822,246.7",
		pos="e,827.6,234.27 847.81,265.49 843.36,258.61 838.13,250.53 833.19,242.91"];
	" progression-free survival "	[height=0.5,
		pos="792.71,326.51",
		width=2.8886];
	" usage " -> " progression-free survival "	[label=" show ",
		lp="814.02,292.65",
		pos="e,819.3,308.9 837.25,297.02 834.2,299.03 831.01,301.15 827.79,303.28"];
	" survival "	[height=0.5,
		pos="902.77,348.97",
		width=1.2277];
	" usage " -> " survival "	[label=" show ",
		lp="896.46,303.95",
		pos="e,891.18,331.43 870.45,300.08 875.04,307.03 880.43,315.18 885.48,322.81"];
	" inhibition monoclonal antibodies "	[height=0.5,
		pos="2684.6,1239",
		width=3.683];
	" inhibition monoclonal antibodies " -> " fgfr domain "	[label=" bind ",
		lp="2648.5,1258.2",
		pos="e,2651.8,1282.6 2671,1257.1 2667,1262.5 2662.4,1268.5 2658,1274.4"];
	" inhibition .31 monoclonal antibodies "	[height=0.5,
		pos="2668,1371.2",
		width=4.0621];
	" inhibition .31 monoclonal antibodies " -> " fgfr domain "	[label=" bind ",
		lp="2639.2,1332.9",
		pos="e,2646,1318.3 2660.4,1352.9 2657.2,1345.3 2653.5,1336.2 2649.9,1327.8"];
	" antibodies "	[height=0.5,
		pos="1976.4,1775.5",
		width=1.4443];
	" antibodies " -> " fgfr3 "	[label=" target ",
		lp="1985.1,1815.3",
		pos="e,2024.2,1830.3 1991.7,1793.1 1999.5,1802 2009,1812.9 2017.4,1822.5"];
	" cellular proliferation "	[height=0.5,
		pos="2056.2,1740.4",
		width=2.4553];
	" antibodies " -> " cellular proliferation "	[label=" inhibitor effect ",
		lp="1964.8,1753.5",
		pos="e,2019,1756.7 2008.8,1761.2 2009.1,1761.1 2009.5,1760.9 2009.8,1760.8"];
	" cellular proliferation positive myeloma cases "	[height=0.5,
		pos="1942,1854.7",
		width=4.8746];
	" antibodies " -> " cellular proliferation positive myeloma cases "	[label=" inhibitor effect ",
		lp="1916.8,1817.9",
		pos="e,1949.9,1836.6 1968.6,1793.5 1964.3,1803.5 1958.8,1816 1954,1827.2"];
	" proliferation multiple myeloma cases "	[height=0.5,
		pos="2044.5,1778.5",
		width=4.1344];
	" antibodies " -> " proliferation multiple myeloma cases "	[label=" inhibitor effect ",
		lp="2072.6,1785.2",
		pos="e,2028.4,1777.8 2028,1777.7 2028.1,1777.7 2028.1,1777.7 2028.2,1777.8"];
	" proliferation "	[height=0.5,
		pos="1921.7,1693",
		width=1.661];
	" antibodies " -> " proliferation "	[label=" inhibitor effect ",
		lp="1929.6,1731",
		pos="e,1933.5,1710.9 1964.5,1757.6 1957.1,1746.5 1947.5,1731.9 1939.2,1719.5"];
	" proliferation positive myeloma cases "	[height=0.5,
		pos="1976.8,1844.4",
		width=4.0802];
	" antibodies " -> " proliferation positive myeloma cases "	[label=" inhibitor effect ",
		lp="2021.1,1812.3",
		pos="e,1976.7,1826.2 1976.5,1793.6 1976.5,1800.4 1976.6,1808.4 1976.6,1815.9"];
	" proliferation " -> " apoptosis mm cells "	[label=" induce ",
		lp="1840.3,1682.5",
		pos="e,1862,1689.9 1862.4,1690 1862.3,1690 1862.2,1690 1862.2,1690"];
	" apoptosis "	[height=0.5,
		pos="1979,1598.5",
		width=1.354];
	" proliferation " -> " apoptosis "	[label=" ultimately lead ",
		lp="1992.7,1657.7",
		pos="e,1968.3,1616.2 1932.5,1675.2 1941,1661.1 1953.1,1641.1 1962.9,1625.1"];
	" apoptosis mm cell lines "	[height=0.5,
		pos="1975.7,1688.5",
		width=2.7803];
	" proliferation " -> " apoptosis mm cell lines "	[label=" lead ",
		lp="1960.1,1696",
		pos="e,1975.7,1688.5 1975.5,1688.5 1975.6,1688.5 1975.6,1688.5 1975.6,1688.5"];
	" vitroa "	[height=0.5,
		pos="1947.7,1639.9",
		width=1.011];
	" proliferation " -> " vitroa "	[label=" induce apoptosis ",
		lp="1932.6,1663.2",
		pos="e,1939,1657.5 1930.5,1675 1931.8,1672.2 1933.2,1669.4 1934.6,1666.5"];
	" monoclonal antibodies "	[height=0.5,
		pos="752.27,2082.8",
		width=2.672];
	" proliferation positive multiple myeloma cases "	[height=0.5,
		pos="828.66,2119.9",
		width=4.9648];
	" monoclonal antibodies " -> " proliferation positive multiple myeloma cases "	[label=" inhibitor effect ",
		lp="831.55,2092.2",
		pos="e,792.12,2102.2 786.89,2099.6 787,2099.7 787.11,2099.7 787.22,2099.8"];
	" cellular proliferation myeloma cases "	[height=0.5,
		pos="745.63,1998",
		width=4.0441];
	" monoclonal antibodies " -> " cellular proliferation myeloma cases "	[label=" inhibitor effect ",
		lp="704.83,2052.8",
		pos="e,747.04,2016.1 750.83,2064.4 749.95,2053.2 748.82,2038.7 747.83,2026.1"];
	" cellular proliferation multiple myeloma cases "	[height=0.5,
		pos="681.96,2131.2",
		width=4.9287];
	" monoclonal antibodies " -> " cellular proliferation multiple myeloma cases "	[label=" inhibitor effect ",
		lp="766.08,2096.4",
		pos="e,708.02,2113.3 726.89,2100.3 723.44,2102.7 719.85,2105.1 716.27,2107.6"];
	" proliferation myeloma cases "	[height=0.5,
		pos="787.01,2160.8",
		width=3.2317];
	" monoclonal antibodies " -> " proliferation myeloma cases "	[label=" inhibitor effect ",
		lp="723.06,2124.6",
		pos="e,778.99,2142.8 760.33,2100.9 764.62,2110.5 770,2122.6 774.8,2133.4"];
	" cellular proliferation positive multiple myeloma cases "	[height=0.5,
		pos="729.29,2164.1",
		width=5.7773];
	" monoclonal antibodies " -> " cellular proliferation positive multiple myeloma cases "	[label=" inhibitor effect ",
		lp="697.69,2126",
		pos="e,734.45,2145.8 747.17,2100.9 744.24,2111.2 740.51,2124.4 737.21,2136.1"];
	" fgfr "	[height=0.5,
		pos="667.59,2074.5",
		width=0.79437];
	" monoclonal antibodies " -> " fgfr "	[label=" target ",
		lp="648.14,2082",
		pos="e,667.61,2074.5 667.65,2074.5 667.64,2074.5 667.64,2074.5 667.63,2074.5"];
	" potential "	[height=0.5,
		pos="834.65,2062",
		width=1.2818];
	" monoclonal antibodies " -> " potential "	[label=" also ",
		lp="795.01,2060.7",
		pos="e,810.25,2068.2 809.93,2068.3 809.98,2068.2 810.04,2068.2 810.09,2068.2"];
	" potential treatment "	[height=0.5,
		pos="692.93,2022.4",
		width=2.2929];
	" monoclonal antibodies " -> " potential treatment "	[label=" also ",
		lp="741.19,2048.8",
		pos="e,710.49,2040.3 734.79,2065 729.4,2059.5 723.37,2053.4 717.6,2047.5"];
	" potential treatment mm "	[height=0.5,
		pos="801.81,2013.9",
		width=2.7623];
	" monoclonal antibodies " -> " potential treatment mm "	[label=" also ",
		lp="774.05,2045",
		pos="e,788.71,2032.1 765.29,2064.7 770.65,2057.3 776.96,2048.5 782.82,2040.3"];
	" study "	[height=0.5,
		pos="109.98,1579.6",
		width=0.95686];
	" promising "	[height=0.5,
		pos="181.19,1569",
		width=1.4443];
	" study " -> " promising "	[label=" conclude ",
		lp="172.11,1582.1",
		pos="e,143.93,1574.6 143.5,1574.6 143.57,1574.6 143.64,1574.6 143.71,1574.6"];
	" agent activity "	[height=0.5,
		pos="1921.2,2849.5",
		width=1.7693];
	" fgfr status.azd4547 "	[height=0.5,
		pos="1965.2,2792.2",
		width=2.3109];
	" agent activity " -> " fgfr status.azd4547 "	[label=" modest ",
		lp="1916.1,2817.4",
		pos="e,1951.4,2810.2 1934.9,2831.7 1938.2,2827.4 1941.8,2822.7 1945.3,2818.2"];
	" single agent activity "	[height=0.5,
		pos="1989.3,2724",
		width=2.4192];
	" single agent activity " -> " fgfr status.azd4547 "	[label=" modest ",
		lp="1955,2760.8",
		pos="e,1971.7,2773.8 1982.9,2742.3 1980.5,2749.1 1977.7,2756.9 1975.1,2764.4"];
	" ccnd1 overexpression "	[height=0.5,
		pos="991.7,2484.3",
		width=2.5637];
	" ccnd1 overexpression " -> " response "	[label=" confer ",
		lp="989.29,2450.4",
		pos="e,953.21,2441.7 975.52,2466.4 970.66,2461 965.24,2455 960.05,2449.3"];
	" bortezomib therapy .47,48 "	[height=0.5,
		pos="1046.7,2545.5",
		width=3.0511];
	" ccnd1 overexpression " -> " bortezomib therapy .47,48 "	[label=" response ",
		lp="988.2,2518.5",
		pos="e,1030.4,2527.4 1007.9,2502.4 1012.8,2507.8 1018.2,2513.9 1023.5,2519.7"];
	" mm patients "	[height=0.5,
		pos="2596.5,2542.5",
		width=1.661];
	" prognosis .49 study "	[height=0.5,
		pos="2667.9,2501",
		width=2.3651];
	" mm patients " -> " prognosis .49 study "	[label=" associate ",
		lp="2655.5,2532.3",
		pos="e,2638.6,2518 2624.3,2526.3 2626.1,2525.3 2627.9,2524.3 2629.7,2523.2"];
	" better prognosis .49 study ndmm patients "	[height=0.5,
		pos="2596.4,2460",
		width=4.5315];
	" mm patients " -> " better prognosis .49 study ndmm patients "	[label=" associate ",
		lp="2567.9,2513.9",
		pos="e,2596.4,2478.3 2596.5,2524.2 2596.5,2513.7 2596.4,2500.4 2596.4,2488.6"];
	" better prognosis .49 study "	[height=0.5,
		pos="2525.8,2585",
		width=2.9789];
	" mm patients " -> " better prognosis .49 study "	[label=" associate ",
		lp="2538.2,2552.9",
		pos="e,2555.1,2567.4 2569.4,2558.8 2567.6,2559.9 2565.8,2560.9 2564,2562"];
	" prognosis .49 study ndmm patients "	[height=0.5,
		pos="2668.5,2583",
		width=3.8997];
	" mm patients " -> " prognosis .49 study ndmm patients "	[label=" associate ",
		lp="2654.9,2551.9",
		pos="e,2636.9,2565.3 2625,2558.5 2625.9,2559.1 2626.9,2559.6 2627.9,2560.2"];
	" prognosis .49 "	[height=0.5,
		pos="2598,2625.1",
		width=1.7693];
	" mm patients " -> " prognosis .49 "	[label=" associate ",
		lp="2568.6,2571.2",
		pos="e,2597.6,2606.8 2596.8,2560.8 2597,2571.3 2597.3,2584.7 2597.5,2596.5"];
	" better prognosis .49 "	[height=0.5,
		pos="2524.7,2501.9",
		width=2.3831];
	" mm patients " -> " better prognosis .49 "	[label=" associate ",
		lp="2537.4,2532.7",
		pos="e,2554.8,2518.9 2568.1,2526.5 2566.6,2525.6 2565.1,2524.7 2563.6,2523.9"];
	" efficacy "	[height=0.5,
		pos="1173.5,287.71",
		width=1.2096];
	" palbociclib "	[height=0.5,
		pos="1249.4,299.49",
		width=1.5165];
	" efficacy " -> " palbociclib "	[label=" safety ",
		lp="1194.7,301.6",
		pos="e,1215,294.15 1214.6,294.08 1214.6,294.09 1214.7,294.1 1214.8,294.12"];
	" combination bortezomib "	[height=0.5,
		pos="1146.1,216",
		width=2.8525];
	" efficacy " -> " combination bortezomib "	[label=" safety ",
		lp="1141.7,249.18",
		pos="e,1153.1,234.34 1166.6,269.62 1163.6,261.78 1160,252.42 1156.7,243.74"];
	" combination bortezomib rrmm "	[height=0.5,
		pos="1125.6,347.7",
		width=3.5025];
	" efficacy " -> " combination bortezomib rrmm "	[label=" safety ",
		lp="1133,320.9",
		pos="e,1139.9,329.76 1159.7,305.06 1155.5,310.27 1150.8,316.1 1146.3,321.74"];
	" objective responses "	[height=0.5,
		pos="908.52,2591.2",
		width=2.347];
	" objective responses " -> " patients "	[label=" achieve ",
		lp="903.29,2548.3",
		pos="e,899.3,2528.8 905.82,2572.9 904.33,2562.8 902.44,2550 900.76,2538.7"];
	" responses "	[height=0.5,
		pos="823.33,2553.2",
		width=1.3902];
	" responses " -> " patients "	[label=" achieve ",
		lp="831.73,2526.5",
		pos="e,871.42,2525.2 849.79,2537.8 853.97,2535.4 858.35,2532.8 862.68,2530.3"];
	" akt "	[height=0.5,
		pos="1391.5,2104.1",
		width=0.75];
	" activation "	[height=0.5,
		pos="1421.3,2014.1",
		width=1.3902];
	" akt " -> " activation "	[label=" play ",
		lp="1389.3,2071.5",
		pos="e,1415.3,2032.1 1397.4,2086.3 1401.6,2073.6 1407.4,2056.2 1412.2,2041.7"];
	" dysregulated activation mtor signaling pathway "	[height=0.5,
		pos="1377.8,2031.4",
		width=5.1093];
	" akt " -> " dysregulated activation mtor signaling pathway "	[label=" hence play ",
		lp="1385.6,2065.3",
		pos="e,1381.2,2049.4 1388.1,2086.1 1386.6,2078.1 1384.8,2068.4 1383.1,2059.5"];
	" dysregulated activation "	[height=0.5,
		pos="1403.1,2178.1",
		width=2.7081];
	" akt " -> " dysregulated activation "	[label=" hence play ",
		lp="1363,2143.5",
		pos="e,1400.2,2160.1 1394.3,2122 1395.6,2130.4 1397.2,2140.6 1398.7,2150"];
	" pi3k53and "	[height=0.5,
		pos="1439.4,2157.1",
		width=1.4624];
	" akt " -> " pi3k53and "	[label=" effect ",
		lp="1430.7,2133.4",
		pos="e,1423.6,2139.5 1405.6,2119.7 1409.1,2123.6 1413,2127.9 1416.8,2132.1"];
	" important role "	[height=0.5,
		pos="1330.7,2117.6",
		width=1.8415];
	" akt " -> " important role "	[label=" hence play ",
		lp="1332.1,2117.3",
		pos="e,1365.3,2109.9 1365.7,2109.8 1365.6,2109.8 1365.6,2109.8 1365.5,2109.9"];
	" mm pathogenesis .54,55 "	[height=0.5,
		pos="1313,2072.2",
		width=2.8525];
	" akt " -> " mm pathogenesis .54,55 "	[label=" hence play activation ",
		lp="1303.7,2101.1",
		pos="e,1353.8,2088.8 1368.4,2094.7 1366.6,2094 1364.8,2093.3 1363,2092.5"];
	" role "	[height=0.5,
		pos="1325.5,2182",
		width=0.81243];
	" akt " -> " role "	[label=" hence play ",
		lp="1328.4,2146.6",
		pos="e,1339.1,2166 1378.1,2119.9 1368.8,2130.9 1356.2,2145.8 1345.6,2158.2"];
	" activation mtor signaling pathway "	[height=0.5,
		pos="1334.6,2034.1",
		width=3.7913];
	" akt " -> " activation mtor signaling pathway "	[label=" hence play ",
		lp="1333.6,2081.7",
		pos="e,1349.2,2052.1 1378.6,2088.2 1371.8,2079.9 1363.4,2069.6 1355.7,2060.1"];
	" program "	[height=0.5,
		pos="1426.8,1932",
		width=1.2818];
	" activation " -> " program "	[label=" upregulating ",
		lp="1385.7,1985.6",
		pos="e,1425.6,1950.2 1422.5,1995.9 1423.2,1985.5 1424.1,1972.2 1424.9,1960.4"];
	" c-myc "	[height=0.5,
		pos="1336.3,2268.2",
		width=1.0652];
	" role " -> " c-myc "	[label=" activation ",
		lp="1299.8,2227.5",
		pos="e,1334,2249.9 1327.8,2200.3 1329.2,2211.7 1331.1,2226.7 1332.7,2239.6"];
	" proliferative effects "	[height=0.5,
		pos="1449.3,2067.1",
		width=2.3651];
	" proliferative effects " -> " akt "	[label=" activate ",
		lp="1446.2,2092.6",
		pos="e,1411.2,2091.5 1422.4,2084.3 1421.6,2084.9 1420.8,2085.4 1419.9,2085.9"];
	" effects "	[height=0.5,
		pos="1489.1,2120.2",
		width=1.0832];
	" effects " -> " akt "	[label=" activate ",
		lp="1440,2104.6",
		pos="e,1417.8,2108.5 1452.2,2114.1 1444.2,2112.8 1435.8,2111.4 1427.9,2110.1"];
	" molecule bromodomain inhibitor "	[height=0.5,
		pos="1556.9,2069.8",
		width=3.7191];
	" effects " -> " molecule bromodomain inhibitor "	[label=" .124 ",
		lp="1533.2,2106.8",
		pos="e,1533,2087.6 1509.8,2104.8 1514.5,2101.4 1519.6,2097.6 1524.6,2093.8"];
	" mtor "	[height=0.5,
		pos="2418,438.5",
		width=0.9027];
	" cell growth "	[height=0.5,
		pos="2493.8,463.25",
		width=1.5526];
	" mtor " -> " cell growth "	[label=" coordinate ",
		lp="2478.9,455.26",
		pos="e,2454.5,450.4 2446.3,447.72 2446.3,447.74 2446.4,447.77 2446.5,447.8"];
	" novel pi3k "	[height=0.5,
		pos="1104,2697.3",
		width=1.4804];
	" decreased osteoclast "	[height=0.5,
		pos="1119.6,2772.5",
		width=2.4192];
	" novel pi3k " -> " decreased osteoclast "	[label=" show ",
		lp="1092.3,2737.5",
		pos="e,1115.9,2754.5 1107.8,2715.5 1109.6,2724.2 1111.8,2734.8 1113.8,2744.5"];
	" osteoclast "	[height=0.5,
		pos="1092.7,2625",
		width=1.3902];
	" novel pi3k " -> " osteoclast "	[label=" show respectively ",
		lp="1046.2,2658.6",
		pos="e,1095.5,2643 1101.2,2679.1 1100,2671.2 1098.5,2661.9 1097.1,2653.1"];
	" pi3k "	[height=0.5,
		pos="1064.1,2827",
		width=0.86659];
	" pi3k " -> " decreased osteoclast "	[label=" show respectively ",
		lp="1034.2,2796.9",
		pos="e,1101.5,2790.4 1080.2,2811.3 1084.6,2807 1089.4,2802.2 1094.2,2797.5"];
	" disruption "	[height=0.5,
		pos="1554,2174.6",
		width=1.4263];
	" disruption " -> " effects "	[label=" research ",
		lp="1551.5,2142.9",
		pos="e,1507.9,2136 1534.2,2158 1528.4,2153.2 1522,2147.9 1515.9,2142.7"];
	" effects compound "	[height=0.5,
		pos="1623.1,2208.8",
		width=2.2026];
	" disruption " -> " effects compound "	[label=" research ",
		lp="1610.4,2181.9",
		pos="e,1589.9,2192.4 1583.7,2189.3 1583.8,2189.4 1583.9,2189.4 1584.1,2189.5"];
	" mtor inhibitor "	[height=0.5,
		pos="1192,2801.1",
		width=1.8234];
	" mtor inhibitor " -> " decreased osteoclast "	[label=" show respectively ",
		lp="1101.4,2793.8",
		pos="e,1154.1,2786.2 1154.5,2786.3 1154.5,2786.3 1154.4,2786.3 1154.3,2786.2"];
	" researched "	[height=0.5,
		pos="86.783,1175.2",
		width=1.4804];
	" silybin "	[height=0.5,
		pos="130.68,1232.6",
		width=1.1013];
	" researched " -> " silybin "	[label=" effect ",
		lp="86.32,1207.6",
		pos="e,117.65,1215.6 100.19,1192.7 103.74,1197.4 107.65,1202.5 111.45,1207.5"];
	" compound "	[height=0.5,
		pos="62.826,1107",
		width=1.4804];
	" researched " -> " compound "	[label=" effect ",
		lp="57.017,1138.5",
		pos="e,69.161,1125 80.488,1157.3 78.059,1150.4 75.224,1142.3 72.545,1134.7"];
	" agents "	[height=0.5,
		pos="1928.9,1018.6",
		width=1.0652];
	" animal studies "	[height=0.5,
		pos="2000.1,1008",
		width=1.8596];
	" agents " -> " animal studies "	[label=" tolerate ",
		lp="1941.3,1020.6",
		pos="e,1966.1,1013.1 1965.7,1013.1 1965.8,1013.1 1965.9,1013.1 1965.9,1013.1"];
	" clioquinol "	[height=0.5,
		pos="2163.5,2547.6",
		width=1.4263];
	" mm .57 "	[height=0.5,
		pos="2237.8,2539.2",
		width=1.2277];
	" clioquinol " -> " mm .57 "	[label=" disrupt integrity ",
		lp="2260.2,2549.5",
		pos="e,2213,2542 2212.7,2542 2212.7,2542 2212.8,2542 2212.8,2542"];
	" clioquinol autophagy leukemia "	[height=0.5,
		pos="2134.5,2460",
		width=3.4844];
	" clioquinol " -> " clioquinol autophagy leukemia "	[label=" inhibit ",
		lp="2172.1,2516.2",
		pos="e,2140.5,2478.1 2157.5,2529.5 2153.5,2517.5 2148.2,2501.5 2143.7,2488"];
	" clioquinol induced autophagy "	[height=0.5,
		pos="2117.9,2624.5",
		width=3.34];
	" clioquinol " -> " clioquinol induced autophagy "	[label=" inhibit ",
		lp="2164.8,2589.2",
		pos="e,2128.6,2606.5 2152.9,2565.5 2147.2,2575.1 2140,2587.2 2133.7,2597.9"];
	" clioquinol induced autophagy leukemia "	[height=0.5,
		pos="2189.4,2615.1",
		width=4.3149];
	" clioquinol " -> " clioquinol induced autophagy leukemia "	[label=" inhibit ",
		lp="2185.3,2569.1",
		pos="e,2182.4,2597 2170.4,2565.7 2173,2572.4 2175.9,2580.1 2178.7,2587.4"];
	" integrity "	[height=0.5,
		pos="2094.4,2593.5",
		width=1.2638];
	" clioquinol " -> " integrity "	[label=" disrupt ",
		lp="2155.7,2575.5",
		pos="e,2117.7,2578 2139.3,2563.6 2135.1,2566.5 2130.6,2569.5 2126.1,2572.4"];
	" mtor activity "	[height=0.5,
		pos="2080.4,2519.3",
		width=1.7151];
	" clioquinol " -> " mtor activity "	[label=" inhibit ",
		lp="2147.6,2527.4",
		pos="e,2120.6,2533 2126.3,2534.9 2126.2,2534.9 2126.1,2534.8 2126,2534.8"];
	" integrity mtorc1 "	[height=0.5,
		pos="2243.1,2500.7",
		width=2.0401];
	" clioquinol " -> " integrity mtorc1 "	[label=" disrupt ",
		lp="2221,2519.8",
		pos="e,2214.8,2517.4 2190,2532 2195.1,2529 2200.6,2525.8 2205.9,2522.6"];
	" mm .57 preclinical studies "	[height=0.5,
		pos="2103.9,2488.1",
		width=3.0692];
	" clioquinol " -> " mm .57 preclinical studies "	[label=" disrupt integrity ",
		lp="2090.1,2529.3",
		pos="e,2121.7,2505.9 2146.3,2530.4 2140.8,2525 2134.8,2518.9 2128.9,2513.1"];
	" clioquinol autophagy "	[height=0.5,
		pos="2211,2469.5",
		width=2.5095];
	" clioquinol " -> " clioquinol autophagy "	[label=" inhibit ",
		lp="2163.1,2520.4",
		pos="e,2200.1,2487.4 2174.3,2529.9 2180.4,2519.9 2188.1,2507.1 2194.9,2496"];
	" mm .57 studies "	[height=0.5,
		pos="2172.3,2470.2",
		width=1.9679];
	" clioquinol " -> " mm .57 studies "	[label=" disrupt integrity ",
		lp="2119.8,2521.4",
		pos="e,2170.2,2488.4 2165.6,2529.3 2166.6,2520.1 2167.9,2508.8 2169.1,2498.6"];
	" association increase "	[height=0.5,
		pos="2075.3,2559.7",
		width=2.3831];
	" clioquinol " -> " association increase "	[label=" induce autophagy ",
		lp="2063.4,2561.7",
		pos="e,2115.1,2554.3 2115.5,2554.2 2115.5,2554.2 2115.4,2554.2 2115.3,2554.2"];
	" association "	[height=0.5,
		pos="2252.7,2574.6",
		width=1.5165];
	" clioquinol " -> " association "	[label=" induce autophagy ",
		lp="2254.5,2551.9",
		pos="e,2212.3,2562.4 2202.4,2559.4 2202.5,2559.4 2202.6,2559.5 2202.7,2559.5"];
	" autophagy "	[height=0.5,
		pos="2228,2615.4",
		width=1.4443];
	" clioquinol " -> " autophagy "	[label=" induce ",
		lp="2214.2,2585.2",
		pos="e,2211.5,2598.1 2179.8,2564.7 2187.3,2572.6 2196.3,2582.1 2204.6,2590.8"];
	" association increase pi3kc3/beclin complex "	[height=0.5,
		pos="2159.1,2640.2",
		width=4.694];
	" clioquinol " -> " association increase pi3kc3/beclin complex "	[label=" induce autophagy ",
		lp="2213.6,2596.3",
		pos="e,2160,2621.9 2162.7,2565.9 2162,2579 2161.2,2596.8 2160.5,2611.7"];
	" histone deacetylases "	[height=0.5,
		pos="1740.2,2636.8",
		width=2.4192];
	" controller gene transcription "	[height=0.5,
		pos="1806.9,2596.8",
		width=3.2136];
	" histone deacetylases " -> " controller gene transcription "	[label=" function ",
		lp="1795.5,2612",
		pos="e,1777.4,2614.5 1768.8,2619.6 1768.9,2619.5 1769,2619.5 1769.1,2619.4"];
	" controller "	[height=0.5,
		pos="1676.6,2592",
		width=1.3902];
	" histone deacetylases " -> " controller "	[label=" function ",
		lp="1685.2,2624.2",
		pos="e,1699.7,2608.3 1715.4,2619.3 1713,2617.6 1710.5,2615.9 1708,2614.1"];
	" chromatin "	[height=0.5,
		pos="1736.9,2713.5",
		width=1.4443];
	" histone deacetylases " -> " chromatin "	[label=" organization ",
		lp="1700.8,2677.7",
		pos="e,1737.7,2695.4 1739.4,2655 1739,2664 1738.6,2675.2 1738.1,2685.4"];
	" hdac function "	[height=0.5,
		pos="657.34,598.24",
		width=1.7693];
	" mm "	[height=0.5,
		pos="735.41,655.32",
		width=0.84854];
	" hdac function " -> " mm "	[label=" dysregulated ",
		lp="655.54,632.57",
		pos="e,716,641.12 680.34,615.06 688.93,621.34 698.77,628.53 707.74,635.09"];
	" sometimes resulting upregulation "	[height=0.5,
		pos="650.01,513",
		width=3.7191];
	" hdac function " -> " sometimes resulting upregulation "	[label=" dysregulated ",
		lp="615.61,568.2",
		pos="e,651.56,531.05 655.78,580.16 654.81,568.86 653.54,554.07 652.44,541.24"];
	" sometimes resulting "	[height=0.5,
		pos="599.84,667.26",
		width=2.4192];
	" hdac function " -> " sometimes resulting "	[label=" dysregulated ",
		lp="670.42,621.25",
		pos="e,614.79,649.31 642.53,616.02 636.07,623.77 628.38,633 621.31,641.48"];
	" upregulation oncogenes "	[height=0.5,
		pos="648.14,668.96",
		width=2.7623];
	" hdac function " -> " upregulation oncogenes "	[label=" sometimes result ",
		lp="703.91,635.92",
		pos="e,650.53,650.56 654.97,616.45 654.02,623.74 652.91,632.3 651.86,640.38"];
	" upregulation "	[height=0.5,
		pos="574.64,624.26",
		width=1.661];
	" hdac function " -> " upregulation "	[label=" result ",
		lp="595.42,604.25",
		pos="e,614.06,611.86 614.53,611.71 614.46,611.74 614.38,611.76 614.3,611.79"];
	" resulting upregulation "	[height=0.5,
		pos="575.92,574.62",
		width=2.5817];
	" hdac function " -> " resulting upregulation "	[label=" dysregulated ",
		lp="574.21,592.79",
		pos="e,612.37,585.2 612.82,585.33 612.74,585.3 612.67,585.28 612.59,585.26"];
	" sometimes resulting upregulation oncogenes "	[height=0.5,
		pos="723.8,561.49",
		width=4.8204];
	" hdac function " -> " sometimes resulting upregulation oncogenes "	[label=" dysregulated ",
		lp="725.34,589.43",
		pos="e,691.71,579.23 686.68,582.02 686.79,581.96 686.89,581.9 687,581.84"];
	" resulting upregulation oncogenes "	[height=0.5,
		pos="604.12,532.87",
		width=3.683];
	" hdac function " -> " resulting upregulation oncogenes "	[label=" dysregulated ",
		lp="595.69,577.31",
		pos="e,619.01,551.17 642.8,580.38 637.49,573.86 631.36,566.34 625.58,559.23"];
	" resulting "	[height=0.5,
		pos="698.86,520.67",
		width=1.2818];
	" hdac function " -> " resulting "	[label=" dysregulated ",
		lp="714.27,571.31",
		pos="e,689.42,538.29 666.97,580.25 672.19,570.49 678.75,558.23 684.56,547.38"];
	" hdac inhibitors "	[height=0.5,
		pos="544.76,2508.1",
		width=1.8957];
	" class "	[height=0.5,
		pos="626.33,2529.6",
		width=0.9027];
	" hdac inhibitors " -> " class "	[label=" represent ",
		lp="564.38,2528.4",
		pos="e,596.82,2521.8 593.15,2520.9 593.3,2520.9 593.46,2521 593.61,2521"];
	" class mm treatment "	[height=0.5,
		pos="503.44,2434.4",
		width=2.3831];
	" hdac inhibitors " -> " class mm treatment "	[label=" represent ",
		lp="555.61,2483.3",
		pos="e,513.5,2452.4 534.76,2490.3 529.87,2481.6 523.89,2470.9 518.47,2461.2"];
	" new class "	[height=0.5,
		pos="471.7,2550.1",
		width=1.3902];
	" hdac inhibitors " -> " new class "	[label=" represent ",
		lp="482.52,2519.7",
		pos="e,498.47,2534.7 515.89,2524.7 513.02,2526.4 510.08,2528.1 507.15,2529.7"];
	" new class mm treatment "	[height=0.5,
		pos="587.35,2580.9",
		width=2.8525];
	" hdac inhibitors " -> " new class mm treatment "	[label=" represent ",
		lp="592.44,2547.5",
		pos="e,576.8,2562.9 555.29,2526.1 560.2,2534.5 566.16,2544.7 571.59,2554"];
	" therapeutic class mm treatment "	[height=0.5,
		pos="523.22,2589.5",
		width=3.5386];
	" hdac inhibitors " -> " therapeutic class mm treatment "	[label=" represent ",
		lp="564.28,2551.5",
		pos="e,527.99,2571.5 539.98,2526.2 537.22,2536.6 533.69,2550 530.58,2561.7"];
	" new therapeutic class "	[height=0.5,
		pos="463.52,2485.6",
		width=2.5276];
	" hdac inhibitors " -> " new therapeutic class "	[label=" represent ",
		lp="468.4,2502.5",
		pos="e,497.09,2494.9 497.5,2495 497.43,2495 497.36,2495 497.29,2495"];
	" new therapeutic class mm treatment "	[height=0.5,
		pos="617.99,2465.8",
		width=4.008];
	" hdac inhibitors " -> " new therapeutic class mm treatment "	[label=" represent ",
		lp="604.93,2497.6",
		pos="e,587.49,2483.4 573.28,2491.6 575.03,2490.6 576.8,2489.6 578.58,2488.6"];
	" therapeutic class "	[height=0.5,
		pos="567.07,2427",
		width=2.0582];
	" hdac inhibitors " -> " therapeutic class "	[label=" represent ",
		lp="583.54,2465",
		pos="e,562.05,2445.2 549.71,2490.1 552.55,2479.8 556.18,2466.6 559.38,2455"];
	" mmset associates "	[height=0.5,
		pos="680.87,424.64",
		width=2.1484];
	" activities "	[height=0.5,
		pos="752.08,414",
		width=1.3179];
	" mmset associates " -> " activities "	[label=" show ",
		lp="727.6,422.39",
		pos="e,746.36,414.85 746.01,414.91 746.07,414.9 746.13,414.89 746.19,414.88"];
	" clinical trials "	[height=0.5,
		pos="1773.2,843",
		width=1.7151];
	" antimyeloma activity hdac inhibitors .65 preclinical settings "	[height=0.5,
		pos="1741.2,909.36",
		width=6.355];
	" clinical trials " -> " antimyeloma activity hdac inhibitors .65 preclinical settings "	[label=" demonstrate ",
		lp="1721.9,879.07",
		pos="e,1749.9,891.25 1764.4,861.13 1761.3,867.57 1757.8,874.97 1754.4,882"];
	" several investigations "	[height=0.5,
		pos="1695.9,969.73",
		width=2.5456];
	" several investigations " -> " antimyeloma activity hdac inhibitors .65 preclinical settings "	[label=" demonstrate ",
		lp="1753,936.15",
		pos="e,1727.6,927.46 1709.5,951.62 1713.3,946.61 1717.4,941.06 1721.4,935.68"];
	" antimyeloma activity preclinical settings "	[height=0.5,
		pos="1640.6,1025.1",
		width=4.4413];
	" several investigations " -> " antimyeloma activity preclinical settings "	[label=" demonstrate ",
		lp="1634.6,1001.1",
		pos="e,1658.8,1006.9 1678.1,987.56 1674.3,991.43 1670.1,995.6 1666,999.7"];
	" several preclinical investigations "	[height=0.5,
		pos="1712.4,1071.4",
		width=3.6469];
	" several preclinical investigations " -> " antimyeloma activity preclinical settings "	[label=" demonstrate ",
		lp="1643.4,1043.6",
		pos="e,1668.5,1043.1 1684.9,1053.7 1682.3,1052 1679.6,1050.2 1676.9,1048.5"];
	" investigations "	[height=0.5,
		pos="1599.8,950.9",
		width=1.7873];
	" investigations " -> " antimyeloma activity preclinical settings "	[label=" demonstrate ",
		lp="1580.2,990.99",
		pos="e,1630.7,1007.1 1609.7,968.86 1614.5,977.64 1620.4,988.38 1625.8,998.12"];
	" preclinical investigations "	[height=0.5,
		pos="1582,1079.3",
		width=2.8886];
	" preclinical investigations " -> " antimyeloma activity hdac inhibitors preclinical settings "	[label=" demonstrate ",
		lp="1519.1,1107.7",
		pos="e,1544.7,1110.1 1560.6,1097 1558,1099.1 1555.4,1101.3 1552.7,1103.5"];
	" preclinical investigations " -> " antimyeloma activity preclinical settings "	[label=" demonstrate ",
		lp="1570,1048.3",
		pos="e,1621.2,1043.1 1601.2,1061.5 1605.2,1057.8 1609.5,1053.9 1613.7,1050"];
	" vantage trial "	[height=0.5,
		pos="1107.8,912.64",
		width=1.661];
	" modest significant difference progression survival "	[height=0.5,
		pos="1190.9,901.62",
		width=5.344];
	" vantage trial " -> " modest significant difference progression survival "	[label=" show ",
		lp="1144.4,912.84",
		pos="e,1163.1,905.3 1162.8,905.35 1162.8,905.34 1162.9,905.34 1163,905.33"];
	" modest significant difference median progression free survival "	[height=0.5,
		pos="1089.4,810",
		width=6.5897];
	" vantage trial " -> " modest significant difference median progression free survival "	[label=" show ",
		lp="1081,873.69",
		pos="e,1092.7,828.19 1104.5,894.29 1101.7,878.67 1097.6,855.99 1094.4,838.09"];
	" modest significant difference median progression survival "	[height=0.5,
		pos="1061.7,1004.1",
		width=6.1564];
	" vantage trial " -> " modest significant difference median progression survival "	[label=" show ",
		lp="1068.5,946.27",
		pos="e,1070.8,986.09 1098.7,930.72 1092,943.87 1082.9,961.92 1075.4,976.83"];
	" median progression free survival "	[height=0.5,
		pos="1161.1,903.19",
		width=3.665];
	" vantage trial " -> " median progression free survival "	[label=" modest difference ",
		lp="1212.5,910.96",
		pos="e,1160.7,903.27 1159.3,903.5 1159.5,903.47 1159.6,903.45 1159.8,903.43"];
	" progression survival "	[height=0.5,
		pos="1037.6,912.45",
		width=2.4192];
	" vantage trial " -> " progression survival "	[label=" statistically significant difference ",
		lp="953.88,919.98",
		pos="e,1047.7,912.48 1047.9,912.48 1047.9,912.48 1047.9,912.48 1047.8,912.48"];
	" median progression survival "	[height=0.5,
		pos="1021.6,857.06",
		width=3.2317];
	" vantage trial " -> " median progression survival "	[label=" difference ",
		lp="1038.4,895.72",
		pos="e,1048.9,874.68 1082.4,896.27 1074.6,891.23 1065.8,885.58 1057.5,880.18"];
	" progression free survival "	[height=0.5,
		pos="1188,857.65",
		width=2.8706];
	" vantage trial " -> " progression free survival "	[label=" modest statistically significant difference ",
		lp="1258.8,881.12",
		pos="e,1162.3,875.28 1131.8,896.14 1138.7,891.41 1146.4,886.16 1153.8,881.1"];
	" difference median progression survival "	[height=0.5,
		pos="1075.1,829.7",
		width=4.2788];
	" vantage trial " -> " difference median progression survival "	[label=" show ",
		lp="1074.8,868.48",
		pos="e,1082.3,847.95 1100.7,894.65 1096.4,883.74 1090.8,869.61 1086,857.32"];
	" significant difference median progression survival "	[height=0.5,
		pos="1150.2,825.2",
		width=5.362];
	" vantage trial " -> " significant difference median progression survival "	[label=" show ",
		lp="1145.3,865.92",
		pos="e,1141.4,843.3 1116.5,894.52 1122.5,882.33 1130.4,866.04 1137,852.31"];
	" modest difference "	[height=0.5,
		pos="1111.6,838.63",
		width=2.2026];
	" vantage trial " -> " modest difference "	[label=" show ",
		lp="1118.7,873.17",
		pos="e,1110.7,856.72 1108.7,894.35 1109.1,886.1 1109.7,876.18 1110.1,867"];
	" modest statistically significant difference progression survival "	[height=0.5,
		pos="1005.4,905.66",
		width=6.5355];
	" vantage trial " -> " modest statistically significant difference progression survival "	[label=" show ",
		lp="1067.8,916.16",
		pos="e,1049.1,908.64 1049.4,908.66 1049.4,908.66 1049.3,908.65 1049.3,908.65"];
	" modest significant difference "	[height=0.5,
		pos="1210.5,919.5",
		width=3.2858];
	" vantage trial " -> " modest significant difference "	[label=" show ",
		lp="1184.9,909.06",
		pos="e,1166.6,916.57 1166.3,916.55 1166.4,916.55 1166.4,916.56 1166.4,916.56"];
	" significant difference median progression free survival "	[height=0.5,
		pos="1199.6,944.51",
		width=5.8134];
	" vantage trial " -> " significant difference median progression free survival "	[label=" show ",
		lp="1165.6,933.8",
		pos="e,1149,926.96 1147,926.25 1147.1,926.28 1147.2,926.31 1147.3,926.34"];
	" statistically significant difference "	[height=0.5,
		pos="1114.8,1013.8",
		width=3.683];
	" vantage trial " -> " statistically significant difference "	[label=" show ",
		lp="1129.4,950.49",
		pos="e,1113.5,995.49 1109,930.72 1110.1,945.87 1111.6,967.76 1112.8,985.26"];
	" modest statistically significant difference median progression free survival "	[height=0.5,
		pos="1144.5,861.8",
		width=7.7813];
	" vantage trial " -> " modest statistically significant difference median progression free survival "	[label=" show ",
		lp="1141.4,884.12",
		pos="e,1131.3,880 1120.6,894.86 1122.1,892.76 1123.7,890.58 1125.3,888.38"];
	" modest difference median progression free survival "	[height=0.5,
		pos="1174.2,835.44",
		width=5.5065];
	" vantage trial " -> " modest difference median progression free survival "	[label=" show ",
		lp="1118.9,885.66",
		pos="e,1158.7,853.42 1122.8,895.12 1131.5,885.1 1142.4,872.34 1152,861.19"];
	" modest significant difference progression free survival "	[height=0.5,
		pos="1027.5,978.56",
		width=5.7953];
	" vantage trial " -> " modest significant difference progression free survival "	[label=" show ",
		lp="1053.8,949.26",
		pos="e,1049.5,960.49 1087.1,929.62 1078.1,937.01 1067.3,945.81 1057.5,953.91"];
	" modest difference progression free survival "	[height=0.5,
		pos="1007.8,939.19",
		width=4.7121];
	" vantage trial " -> " modest difference progression free survival "	[label=" show ",
		lp="1044.2,917.12",
		pos="e,1062.4,924.68 1062.7,924.59 1062.7,924.61 1062.6,924.62 1062.6,924.64"];
	" difference median progression free survival "	[height=0.5,
		pos="1031.1,949.57",
		width=4.7301];
	" vantage trial " -> " difference median progression free survival "	[label=" show ",
		lp="1093.9,920.71",
		pos="e,1067.7,931.92 1075.7,928.09 1075.5,928.17 1075.4,928.25 1075.2,928.33"];
	" statistically significant difference median progression survival "	[height=0.5,
		pos="1082.2,877.07",
		width=6.5355];
	" vantage trial " -> " statistically significant difference median progression survival "	[label=" show ",
		lp="1076.4,887.25",
		pos="e,1094.7,894.44 1095,894.86 1094.9,894.79 1094.9,894.72 1094.8,894.65"];
	" modest statistically significant difference progression free survival "	[height=0.5,
		pos="1019.4,882.4",
		width=6.9688];
	" vantage trial " -> " modest statistically significant difference progression free survival "	[label=" show ",
		lp="1049.7,906.59",
		pos="e,1068,899.02 1068.2,899.11 1068.2,899.1 1068.1,899.08 1068.1,899.06"];
	" significant difference progression free survival "	[height=0.5,
		pos="1138.7,998.68",
		width=5.019];
	" vantage trial " -> " significant difference progression free survival "	[label=" show ",
		lp="1121.5,943.42",
		pos="e,1132.2,980.46 1114.3,930.89 1118.5,942.52 1124,957.83 1128.8,970.95"];
	" difference "	[height=0.5,
		pos="1162.4,1001.3",
		width=1.4263];
	" vantage trial " -> " difference "	[label=" show ",
		lp="1114,945.22",
		pos="e,1151.6,983.72 1118.8,930.59 1126.7,943.3 1137.3,960.55 1146.1,974.84"];
	" modest difference median progression survival "	[height=0.5,
		pos="1088.3,1009.6",
		width=5.0732];
	" vantage trial " -> " modest difference median progression survival "	[label=" show ",
		lp="1080.5,948.64",
		pos="e,1091.9,991.47 1104.1,930.89 1101.2,945.11 1097.2,965.12 1094,981.4"];
	" difference progression survival "	[height=0.5,
		pos="1125.2,811.45",
		width=3.4844];
	" vantage trial " -> " difference progression survival "	[label=" show ",
		lp="1134.1,874.76",
		pos="e,1122,829.72 1110.9,894.55 1113.5,879.39 1117.3,857.48 1120.3,839.96"];
	" significant difference "	[height=0.5,
		pos="1192.6,972.23",
		width=2.5095];
	" vantage trial " -> " significant difference "	[label=" show ",
		lp="1163.9,931.62",
		pos="e,1167.9,954.89 1131.4,929.24 1140.1,935.36 1150.1,942.4 1159.5,949"];
	" modest difference progression survival "	[height=0.5,
		pos="1071.3,947.74",
		width=4.2607];
	" vantage trial " -> " modest difference progression survival "	[label=" show ",
		lp="1070.9,937.8",
		pos="e,1089.1,930.61 1089.5,930.19 1089.5,930.26 1089.4,930.33 1089.3,930.4"];
	" significant difference progression survival "	[height=0.5,
		pos="1053.6,858.88",
		width=4.5677];
	" vantage trial " -> " significant difference progression survival "	[label=" show ",
		lp="1066.2,897.21",
		pos="e,1071.7,876.89 1090.3,895.33 1086.7,891.74 1082.8,887.89 1079,884.08"];
	" statistically significant difference median progression free survival "	[height=0.5,
		pos="1205,879.02",
		width=6.9869];
	" vantage trial " -> " statistically significant difference median progression free survival "	[label=" show ",
		lp="1128.8,906.49",
		pos="e,1153.8,896.74 1147,899.06 1147.2,899.01 1147.3,898.97 1147.5,898.92"];
	" statistically significant difference progression free survival "	[height=0.5,
		pos="1110.8,976.97",
		width=6.1925];
	" vantage trial " -> " statistically significant difference progression free survival "	[label=" show ",
		lp="1127.6,947.2",
		pos="e,1110,958.88 1108.6,930.9 1108.9,936.38 1109.2,942.53 1109.5,948.5"];
	" difference progression free survival "	[height=0.5,
		pos="1145.2,944.76",
		width=3.9358];
	" vantage trial " -> " difference progression free survival "	[label=" show ",
		lp="1109.4,922.42",
		pos="e,1128.2,930.19 1127.8,929.83 1127.9,929.89 1127.9,929.95 1128,930.01"];
	" statistically significant difference progression survival "	[height=0.5,
		pos="1044,830.57",
		width=5.7412];
	" vantage trial " -> " statistically significant difference progression survival "	[label=" show ",
		lp="1060.7,868.33",
		pos="e,1058,848.63 1093.9,894.83 1085.3,883.73 1074,869.23 1064.4,856.82"];
	" modest statistically significant difference "	[height=0.5,
		pos="1057.3,980.22",
		width=4.4774];
	" vantage trial " -> " modest statistically significant difference "	[label=" show ",
		lp="1067.3,949.55",
		pos="e,1071,961.88 1094.5,930.4 1089.2,937.52 1083,945.88 1077.1,953.7"];
	" modest statistically significant difference median progression survival "	[height=0.5,
		pos="1168.4,969.35",
		width=7.3299];
	" vantage trial " -> " modest statistically significant difference median progression survival "	[label=" show ",
		lp="1115.5,944.68",
		pos="e,1149.1,951.35 1126.3,929.97 1131.2,934.52 1136.5,939.52 1141.7,944.39"];
	" results "	[height=0.5,
		pos="494,1904.7",
		width=1.0652];
	" fda approval combination bortezomib "	[height=0.5,
		pos="569.88,1916.5",
		width=4.1524];
	" results " -> " fda approval combination bortezomib "	[label=" result ",
		lp="549.72,1917.9",
		pos="e,531.06,1910.5 530.61,1910.4 530.69,1910.4 530.76,1910.4 530.84,1910.4"];
	" fda approval "	[height=0.5,
		pos="466.63,1833",
		width=1.661];
	" results " -> " fda approval "	[label=" result ",
		lp="463.2,1866.3",
		pos="e,473.51,1851 487.24,1887 484.2,1879 480.54,1869.5 477.16,1860.6"];
	" fda approval combination "	[height=0.5,
		pos="446.12,1964.7",
		width=2.9608];
	" results " -> " fda approval combination "	[label=" result ",
		lp="454.73,1937.6",
		pos="e,460.58,1946.6 480.41,1921.7 476.25,1927 471.57,1932.8 467.04,1938.5"];
	" nf-kb "	[height=0.5,
		pos="1236.7,2190.4",
		width=0.95686];
	" nf-kb " -> " role "	[label=" play ",
		lp="1286.3,2178.9",
		pos="e,1296.6,2184.7 1270.8,2187.2 1275.9,2186.7 1281.1,2186.2 1286.2,2185.7"];
	" pathogenesis mm "	[height=0.5,
		pos="1186.4,2252.9",
		width=2.1665];
	" nf-kb " -> " pathogenesis mm "	[label=" play role ",
		lp="1187.4,2224.4",
		pos="e,1201,2234.8 1223.2,2207.1 1218.4,2213.1 1212.8,2220.1 1207.5,2226.7"];
	" pathogenesis "	[height=0.5,
		pos="1159.6,2158.6",
		width=1.6971];
	" nf-kb " -> " pathogenesis "	[label=" play role ",
		lp="1178.9,2185.6",
		pos="e,1195.2,2173.2 1209.3,2179.1 1207.7,2178.4 1206.1,2177.8 1204.5,2177.1"];
	" pathway "	[height=0.5,
		pos="630.88,2858.2",
		width=1.2638];
	" constitutively active "	[height=0.5,
		pos="674.78,2915.6",
		width=2.4192];
	" pathway " -> " constitutively active "	[label=" become ",
		lp="624.08,2890.2",
		pos="e,661.15,2897.8 644.29,2875.7 647.63,2880.1 651.29,2884.9 654.87,2889.6"];
	" active "	[height=0.5,
		pos="606.93,2790",
		width=1.011];
	" pathway " -> " active "	[label=" become ",
		lp="595.12,2821.5",
		pos="e,613.26,2808 624.59,2840.3 622.16,2833.4 619.33,2825.3 616.65,2817.7"];
	" potential mechanism "	[height=0.5,
		pos="1844,463.51",
		width=2.4914];
	" proliferation cancerous cells "	[height=0.5,
		pos="1915.4,422.01",
		width=3.2136];
	" potential mechanism " -> " proliferation cancerous cells "	[label=" lead ",
		lp="1890.4,438.05",
		pos="e,1885.1,439.63 1873.5,446.39 1874.4,445.83 1875.4,445.27 1876.4,444.71"];
	" pathway becomes "	[height=0.5,
		pos="1843.9,381",
		width=2.2026];
	" potential mechanism " -> " pathway becomes "	[label=" lead ",
		lp="1828.4,434.88",
		pos="e,1843.9,399.26 1844,445.2 1844,434.73 1843.9,421.37 1843.9,409.55"];
	" enhanced proliferation cells "	[height=0.5,
		pos="1773.3,505.96",
		width=3.1594];
	" potential mechanism " -> " enhanced proliferation cells "	[label=" lead ",
		lp="1797.8,474.45",
		pos="e,1802.7,488.3 1815.2,480.78 1814,481.55 1812.6,482.34 1811.3,483.12"];
	" enhanced proliferation cancerous cells "	[height=0.5,
		pos="1916,504.05",
		width=4.2066];
	" potential mechanism " -> " enhanced proliferation cancerous cells "	[label=" lead ",
		lp="1859.3,473.33",
		pos="e,1884.4,486.25 1874.1,480.47 1874.5,480.71 1875,480.95 1875.4,481.19"];
	" proliferation cells "	[height=0.5,
		pos="1845.5,546.07",
		width=2.1665];
	" potential mechanism " -> " proliferation cells "	[label=" lead ",
		lp="1829.1,492.17",
		pos="e,1845.1,527.8 1844.3,481.83 1844.5,492.31 1844.8,505.67 1845,517.5"];
	" enhanced proliferation "	[height=0.5,
		pos="1772.2,422.9",
		width=2.6359];
	" potential mechanism " -> " enhanced proliferation "	[label=" lead ",
		lp="1797.3,453.34",
		pos="e,1802.8,440.21 1814,446.52 1813.2,446.07 1812.4,445.61 1811.6,445.15"];
	" nf-kb pathway activation "	[height=0.5,
		pos="311.52,1146.2",
		width=2.8886];
	" mm lytic bone disease "	[height=0.5,
		pos="330.87,1215.9",
		width=2.6539];
	" nf-kb pathway activation " -> " mm lytic bone disease "	[label=" lead ",
		lp="304.31,1183.6",
		pos="e,325.75,1197.5 316.6,1164.5 318.57,1171.6 320.86,1179.8 323.02,1187.6"];
	" mm bone disease "	[height=0.5,
		pos="310.68,1074",
		width=2.1484];
	" nf-kb pathway activation " -> " mm bone disease "	[label=" lead ",
		lp="295.66,1107.6",
		pos="e,310.9,1092.2 311.31,1128 311.22,1120.2 311.11,1110.9 311.01,1102.3"];
	" pathway activation "	[height=0.5,
		pos="331.23,1288.2",
		width=2.2929];
	" pathway activation " -> " mm lytic bone disease "	[label=" additionally lead ",
		lp="281.57,1249.6",
		pos="e,330.96,1234.1 331.14,1269.9 331.1,1262.1 331.05,1252.9 331.01,1244.2"];
	" cyclin d1expression .89,90 proteasome inhibitors91 "	[height=0.5,
		pos="1594.4,259.64",
		width=5.5245];
	" osteoclasts .87,88 nf-kb "	[height=0.5,
		pos="1665.6,249",
		width=2.7803];
	" cyclin d1expression .89,90 proteasome inhibitors91 " -> " osteoclasts .87,88 nf-kb "	[label=" activate ",
		lp="1640.6,256.51",
		pos="e,1665.6,249 1665.6,249.01 1665.6,249.01 1665.6,249.01 1665.6,249"];
	" uematsu et al . "	[height=0.5,
		pos="1741.3,2436.5",
		width=1.8776];
	" uematsu et al . " -> " studies "	[label=" treat mm xenograft mouse model ",
		lp="1657.2,2410.1",
		pos="e,1762.1,2377.4 1747.7,2418.3 1751,2408.9 1755.1,2397.3 1758.7,2386.9"];
	" mm xenograft mouse model "	[height=0.5,
		pos="1710.5,2505.8",
		width=3.2497];
	" uematsu et al . " -> " mm xenograft mouse model "	[label=" treat ",
		lp="1712,2474",
		pos="e,1718.7,2487.5 1733.2,2454.7 1730,2461.9 1726.3,2470.3 1722.8,2478.2"];
	" murine double minute "	[height=0.5,
		pos="2855.8,977.21",
		width=2.6359];
	" functions "	[height=0.5,
		pos="2899.7,1034.6",
		width=1.336];
	" murine double minute " -> " functions "	[label=" pleiotropic protein ",
		lp="2820.2,1009.4",
		pos="e,2886.2,1017 2869.5,995.06 2872.8,999.42 2876.4,1004.2 2880,1008.8"];
	" functions e3 ubiquitin ligase "	[height=0.5,
		pos="2831.9,909",
		width=3.2317];
	" murine double minute " -> " functions e3 ubiquitin ligase "	[label=" protein ",
		lp="2822.5,940.35",
		pos="e,2838.3,927.33 2849.4,958.93 2847,952.12 2844.2,944.24 2841.6,936.77"];
	" function "	[height=0.5,
		pos="120.38,2272.6",
		width=1.2457];
	" tp53 .94 "	[height=0.5,
		pos="191.59,2262",
		width=1.2457];
	" function " -> " tp53 .94 "	[label=" accumulation ",
		lp="142.21,2258.8",
		pos="e,162.98,2266.3 162.62,2266.3 162.68,2266.3 162.74,2266.3 162.8,2266.3"];
	" ubiquitination "	[height=0.5,
		pos="2474.9,2759.2",
		width=1.8054];
	" proteasomemediated degradation "	[height=0.5,
		pos="2518.8,2816.6",
		width=3.7011];
	" ubiquitination " -> " proteasomemediated degradation "	[label=" facilitate ",
		lp="2466.2,2791.3",
		pos="e,2505,2798.6 2488.5,2777.1 2491.8,2781.3 2495.4,2786 2498.8,2790.6"];
	" degradation "	[height=0.5,
		pos="2450.9,2691",
		width=1.5887];
	" ubiquitination " -> " degradation "	[label=" facilitate ",
		lp="2437.1,2722.5",
		pos="e,2457.3,2709 2468.6,2741.3 2466.1,2734.4 2463.3,2726.3 2460.6,2718.7"];
	" data "	[height=0.5,
		pos="455.74,353.71",
		width=0.84854];
	" investigation "	[height=0.5,
		pos="531.62,365.49",
		width=1.6971];
	" data " -> " investigation "	[label=" support ",
		lp="509.86,365.81",
		pos="e,485.55,358.34 485.3,358.3 485.34,358.31 485.38,358.31 485.42,358.32"];
	" investigation therapeutic intervention c-myc/wnt "	[height=0.5,
		pos="428.36,282",
		width=5.2176];
	" data " -> " investigation therapeutic intervention c-myc/wnt "	[label=" support ",
		lp="419.44,315.29",
		pos="e,435.24,300.02 448.97,335.99 445.94,328.03 442.28,318.46 438.9,309.6"];
	" nutlin-induceda apoptosis mm cells "	[height=0.5,
		pos="407.86,413.7",
		width=3.9358];
	" data " -> " nutlin-induceda apoptosis mm cells "	[label=" demonstrate ",
		lp="398.13,386.41",
		pos="e,422.27,395.64 442.66,370.1 438.32,375.54 433.37,381.74 428.6,387.71"];
	" preclinical data "	[height=0.5,
		pos="2023,1518.7",
		width=1.9318];
	" preclinical data " -> " apoptosis "	[label=" demonstrate ",
		lp="1965.8,1561.9",
		pos="e,1988.8,1580.8 2013,1536.8 2007.3,1547.2 2000,1560.4 1993.6,1571.9"];
	" investigation intervention "	[height=0.5,
		pos="2112.8,1525.4",
		width=2.9428];
	" preclinical data " -> " investigation intervention "	[label=" support ",
		lp="2065.7,1531.2",
		pos="e,2090.4,1523.7 2090.1,1523.7 2090.2,1523.7 2090.2,1523.7 2090.3,1523.7"];
	" investigation intervention c-myc/wnt "	[height=0.5,
		pos="1994,1437",
		width=4.0621];
	" preclinical data " -> " investigation intervention c-myc/wnt "	[label=" support ",
		lp="1985.6,1490",
		pos="e,2000.4,1455.1 2016.5,1500.5 2012.8,1490 2008,1476.4 2003.7,1464.5"];
	" nutlin-induceda apoptosis "	[height=0.5,
		pos="2091.1,1476",
		width=2.9608];
	" preclinical data " -> " nutlin-induceda apoptosis "	[label=" demonstrate ",
		lp="2089.7,1492.9",
		pos="e,2063.1,1493.6 2049.9,1501.8 2051.4,1500.9 2052.9,1500 2054.4,1499"];
	" investigation therapeutic intervention "	[height=0.5,
		pos="2044.4,1441",
		width=4.0982];
	" preclinical data " -> " investigation therapeutic intervention "	[label=" support ",
		lp="2056.8,1477.2",
		pos="e,2039.4,1459.2 2028,1500.6 2030.6,1491.2 2033.8,1479.4 2036.7,1468.8"];
	" increased activity "	[height=0.5,
		pos="1240.4,1891.4",
		width=2.1484];
	" biogenesis "	[height=0.5,
		pos="1211.4,1820.3",
		width=1.4624];
	" increased activity " -> " biogenesis "	[label=" upregulates ",
		lp="1262.8,1853.1",
		pos="e,1218.8,1838.5 1233.1,1873.4 1229.9,1865.7 1226.1,1856.4 1222.6,1847.8"];
	" ribosomal biogenesis "	[height=0.5,
		pos="1170.5,1851.5",
		width=2.5276];
	" increased activity " -> " ribosomal biogenesis "	[label=" upregulates ",
		lp="1245.4,1866.7",
		pos="e,1200.8,1868.8 1211.2,1874.7 1210.6,1874.4 1210.1,1874.1 1209.5,1873.8"];
	" biogenesis " -> " myc "	[label=" activity ",
		lp="1196,1794.7",
		pos="e,1154.1,1794.3 1179.5,1805.8 1174.3,1803.4 1168.8,1800.9 1163.5,1798.5"];
	" ribosomal biogenesis " -> " myc "	[label=" increase activity ",
		lp="1104,1813.8",
		pos="e,1139.9,1800.3 1159.8,1833.6 1155.3,1826.1 1150,1817.3 1145.1,1809.1"];
	" key role "	[height=0.5,
		pos="1340.5,2347.5",
		width=1.2277];
	" key role " -> " c-myc "	[label=" pathologic activation ",
		lp="1277.7,2320.5",
		pos="e,1337.3,2286.4 1339.5,2329.5 1339,2319.8 1338.4,2307.5 1337.8,2296.4"];
	" rocaglates "	[height=0.5,
		pos="2224.1,744.16",
		width=1.4263];
	" translation messenger rnas "	[height=0.5,
		pos="2313.7,722.53",
		width=3.0511];
	" rocaglates " -> " translation messenger rnas "	[label=" repress ",
		lp="2243.6,741.4",
		pos="e,2266.8,733.85 2266.5,733.91 2266.6,733.9 2266.6,733.89 2266.7,733.88"];
	" translation specific messenger rnas "	[height=0.5,
		pos="2190.5,648.45",
		width=3.8635];
	" rocaglates " -> " translation specific messenger rnas "	[label=" repress ",
		lp="2186,708.66",
		pos="e,2196.9,666.7 2217.8,726.15 2212.8,712.08 2205.9,692.26 2200.2,676.16"];
	" translation "	[height=0.5,
		pos="2173.5,828.63",
		width=1.4624];
	" rocaglates " -> " translation "	[label=" repress ",
		lp="2178.4,774.61",
		pos="e,2184.2,810.74 2213.4,762.07 2206.4,773.72 2197.2,789.11 2189.4,802.15"];
	" translation oncogenic program related high expression myc "	[height=0.5,
		pos="2285.2,770.77",
		width=6.2828];
	" rocaglates " -> " translation oncogenic program related high expression myc "	[label=" inhibit ",
		lp="2278.1,750.78",
		pos="e,2256.8,758.39 2256.5,758.24 2256.5,758.27 2256.6,758.29 2256.6,758.32"];
	" specific translation oncogenic program related expression myc "	[height=0.5,
		pos="2163.3,743.07",
		width=6.5897];
	" rocaglates " -> " specific translation oncogenic program related expression myc "	[label=" inhibit ",
		lp="2151.3,750.74",
		pos="e,2172.6,743.23 2172.8,743.24 2172.8,743.24 2172.7,743.24 2172.7,743.24"];
	" specific translation oncogenic program related high expression myc "	[height=0.5,
		pos="2146,679.04",
		width=7.0952];
	" rocaglates " -> " specific translation oncogenic program related high expression myc "	[label=" inhibit ",
		lp="2168.2,722.99",
		pos="e,2167.7,697.12 2204,727.39 2195.3,720.15 2185,711.53 2175.4,703.59"];
	" translation oncogenic program related high expression "	[height=0.5,
		pos="2310.7,693.81",
		width=5.7773];
	" rocaglates " -> " translation oncogenic program related high expression "	[label=" inhibit ",
		lp="2239.4,715.24",
		pos="e,2279.8,711.74 2251,728.5 2257.3,724.85 2264.1,720.89 2270.8,716.99"];
	" specific translation program related expression myc "	[height=0.5,
		pos="2173.5,678.56",
		width=5.5245];
	" rocaglates " -> " specific translation program related expression myc "	[label=" inhibit ",
		lp="2180.7,708.24",
		pos="e,2187.4,696.65 2210.6,726.58 2205.4,719.92 2199.4,712.19 2193.8,704.91"];
	" translation program "	[height=0.5,
		pos="2261.4,650.97",
		width=2.3651];
	" rocaglates " -> " translation program "	[label=" inhibit ",
		lp="2262.3,709.96",
		pos="e,2254.1,669.2 2231.3,726.19 2236.7,712.74 2244.1,694.09 2250.3,678.73"];
	" translation oncogenic program "	[height=0.5,
		pos="2207.9,681.54",
		width=3.4483];
	" rocaglates " -> " translation oncogenic program "	[label=" inhibit ",
		lp="2238.8,710.31",
		pos="e,2212.6,699.82 2219.4,726.04 2218.1,720.9 2216.6,715.17 2215.2,709.58"];
	" translation program related high expression myc "	[height=0.5,
		pos="2124.9,732.98",
		width=5.2176];
	" rocaglates " -> " translation program related high expression myc "	[label=" inhibit ",
		lp="2153.5,746.13",
		pos="e,2174.8,738.6 2175.1,738.64 2175.1,738.63 2175,738.62 2175,738.62"];
	" translation oncogenic program related "	[height=0.5,
		pos="2325,749.34",
		width=4.1705];
	" rocaglates " -> " translation oncogenic program related "	[label=" inhibit ",
		lp="2296.7,754.28",
		pos="e,2275.5,746.8 2275.2,746.78 2275.2,746.78 2275.3,746.79 2275.3,746.79"];
	" translation oncogenic program related expression "	[height=0.5,
		pos="2316.7,783.84",
		width=5.2898];
	" rocaglates " -> " translation oncogenic program related expression "	[label=" inhibit ",
		lp="2239.9,752.63",
		pos="e,2275.4,766.15 2256.8,758.15 2259.8,759.44 2262.9,760.77 2266,762.11"];
	" translation oncogenic program related expression myc "	[height=0.5,
		pos="2235.8,841.34",
		width=5.7773];
	" rocaglates " -> " translation oncogenic program related expression myc "	[label=" inhibit ",
		lp="2250.9,780.25",
		pos="e,2233.6,823.14 2226.3,762.44 2228,776.69 2230.5,796.74 2232.4,813.06"];
	" specific translation program related "	[height=0.5,
		pos="2251.5,684.21",
		width=3.9177];
	" rocaglates " -> " specific translation program related "	[label=" inhibit ",
		lp="2214.2,726.33",
		pos="e,2243.3,702.18 2232.3,726.17 2234.4,721.55 2236.8,716.47 2239,711.49"];
	" specific translation oncogenic program related "	[height=0.5,
		pos="2289.9,670.61",
		width=4.9829];
	" rocaglates " -> " specific translation oncogenic program related "	[label=" inhibit ",
		lp="2274.8,719.07",
		pos="e,2273.8,688.68 2239.7,726.73 2247.8,717.68 2257.9,706.44 2266.9,696.41"];
	" specific translation oncogenic program related high expression "	[height=0.5,
		pos="2143.4,805.35",
		width=6.5897];
	" rocaglates " -> " specific translation oncogenic program related high expression "	[label=" inhibit ",
		lp="2167.4,778.38",
		pos="e,2167.1,787.4 2202.5,760.55 2194.1,766.9 2184.4,774.29 2175.3,781.21"];
	" specific translation oncogenic program "	[height=0.5,
		pos="2128.5,768.12",
		width=4.2607];
	" rocaglates " -> " specific translation oncogenic program "	[label=" inhibit ",
		lp="2160.6,747.18",
		pos="e,2181.9,754.74 2182.2,754.66 2182.1,754.68 2182.1,754.69 2182,754.7"];
	" translation program related expression myc "	[height=0.5,
		pos="2164.9,785.39",
		width=4.7121];
	" rocaglates " -> " translation program related expression myc "	[label=" inhibit ",
		lp="2221.3,753.62",
		pos="e,2190.5,767.58 2200.7,760.45 2200.1,760.89 2199.4,761.33 2198.8,761.78"];
	" specific translation program "	[height=0.5,
		pos="2271.9,725.81",
		width=3.1775];
	" rocaglates " -> " specific translation program "	[label=" inhibit ",
		lp="2280.4,738.29",
		pos="e,2259.2,730.69 2258.8,730.82 2258.9,730.8 2259,730.78 2259,730.76"];
	" translation program related high expression "	[height=0.5,
		pos="2143.4,708.89",
		width=4.7121];
	" rocaglates " -> " translation program related high expression "	[label=" inhibit ",
		lp="2170.1,722.46",
		pos="e,2183.5,726.41 2191.8,730.01 2191.7,729.98 2191.6,729.94 2191.5,729.9"];
	" specific translation program related expression "	[height=0.5,
		pos="2251.9,804.95",
		width=5.019];
	" rocaglates " -> " specific translation program related expression "	[label=" inhibit ",
		lp="2257.4,777.38",
		pos="e,2243.7,786.95 2232.3,762.07 2234.5,766.97 2237,772.4 2239.4,777.7"];
	" specific translation program related high expression myc "	[height=0.5,
		pos="2270.4,833.72",
		width=6.03];
	" rocaglates " -> " specific translation program related high expression myc "	[label=" inhibit ",
		lp="2223.5,791.98",
		pos="e,2261,815.62 2233.5,762.28 2240.1,775.03 2249,792.31 2256.4,806.68"];
	" translation program related "	[height=0.5,
		pos="2204.5,840.58",
		width=3.1053];
	" rocaglates " -> " translation program related "	[label=" inhibit ",
		lp="2193.8,794.91",
		pos="e,2208.2,822.53 2220.4,762.29 2217.6,776.43 2213.5,796.32 2210.2,812.52"];
	" specific translation program related high expression "	[height=0.5,
		pos="2227.3,645",
		width=5.5245];
	" rocaglates " -> " specific translation program related high expression "	[label=" inhibit ",
		lp="2204.1,692.23",
		pos="e,2226.8,663.07 2224.7,725.97 2225.2,711.29 2225.9,690.38 2226.4,673.49"];
	" specific translation oncogenic program related expression "	[height=0.5,
		pos="2296.2,811.33",
		width=6.1022];
	" rocaglates " -> " specific translation oncogenic program related expression "	[label=" inhibit ",
		lp="2277.4,781.24",
		pos="e,2276.8,793.2 2242.3,761.11 2250.5,768.76 2260.4,777.95 2269.4,786.37"];
	" translation program related expression "	[height=0.5,
		pos="2204.9,800.84",
		width=4.2066];
	" rocaglates " -> " translation program related expression "	[label=" inhibit ",
		lp="2194.7,775.1",
		pos="e,2211,782.83 2218.1,762.09 2216.9,765.61 2215.6,769.37 2214.3,773.12"];
	" deletion "	[height=0.5,
		pos="810.73,608.45",
		width=1.2277];
	" deletion " -> " mm "	[label=" aberration ",
		lp="807.35,637.65",
		pos="e,756.57,642.15 786.48,623.54 779.71,627.75 772.27,632.38 765.22,636.77"];
	" mutation "	[height=0.5,
		pos="712.28,741.88",
		width=1.3179];
	" mutation " -> " mm "	[label=" genomic aberration ",
		lp="665.55,695.94",
		pos="e,730.62,673.23 717.07,723.94 720.23,712.11 724.44,696.36 728.03,682.94"];
	" tumor suppressor gene "	[height=0.5,
		pos="2189.1,330.11",
		width=2.672];
	" common aberration "	[height=0.5,
		pos="2270.6,351.62",
		width=2.3651];
	" tumor suppressor gene " -> " common aberration "	[label=" deletion ",
		lp="2270.9,352.34",
		pos="e,2245.2,344.91 2244.8,344.82 2244.9,344.83 2244.9,344.85 2245,344.86"];
	" genomic aberration mm "	[height=0.5,
		pos="2147.7,256.44",
		width=2.8164];
	" tumor suppressor gene " -> " genomic aberration mm "	[label=" deletion ",
		lp="2144.8,290.05",
		pos="e,2157.8,274.44 2178.8,311.9 2174,303.25 2168.1,292.73 2162.7,283.19"];
	" aberration "	[height=0.5,
		pos="2116,372.11",
		width=1.4263];
	" tumor suppressor gene " -> " aberration "	[label=" deletion ",
		lp="2181.3,357.05",
		pos="e,2142.8,356.71 2158.9,347.44 2156.5,348.83 2154,350.24 2151.6,351.66"];
	" common aberration mm "	[height=0.5,
		pos="2231.6,402.9",
		width=2.8525];
	" tumor suppressor gene " -> " common aberration mm "	[label=" deletion ",
		lp="2233.7,369.54",
		pos="e,2221.1,384.86 2199.6,348.11 2204.5,356.51 2210.5,366.68 2215.9,375.97"];
	" genomic aberration "	[height=0.5,
		pos="2167.5,411.54",
		width=2.347];
	" tumor suppressor gene " -> " genomic aberration "	[label=" deletion ",
		lp="2205.6,373.45",
		pos="e,2172.3,393.52 2184.3,348.18 2181.5,358.62 2178,371.97 2174.9,383.72"];
	" common genomic aberration "	[height=0.5,
		pos="2107.8,307.64",
		width=3.2858];
	" tumor suppressor gene " -> " common genomic aberration "	[label=" deletion ",
		lp="2108.8,322.6",
		pos="e,2134.5,315.03 2134.9,315.12 2134.8,315.11 2134.8,315.09 2134.7,315.07"];
	" aberration mm "	[height=0.5,
		pos="2262.3,287.82",
		width=1.8957];
	" tumor suppressor gene " -> " aberration mm "	[label=" deletion ",
		lp="2247.9,303.67",
		pos="e,2233.7,304.32 2218.8,312.91 2220.8,311.76 2222.9,310.59 2224.9,309.42"];
	" common genomic aberration mm "	[height=0.5,
		pos="2211.4,249",
		width=3.7733];
	" tumor suppressor gene " -> " common genomic aberration mm "	[label=" deletion ",
		lp="2185.8,287.04",
		pos="e,2206.3,267.23 2194,312.11 2196.8,301.79 2200.5,288.6 2203.7,276.96"];
	" cyld "	[height=0.5,
		pos="571.74,1023.5",
		width=0.84854];
	" negative regulator nf-κb "	[height=0.5,
		pos="655.35,1024.1",
		width=2.8164];
	" cyld " -> " negative regulator nf-κb "	[label=" act ",
		lp="614.47,1031.2",
		pos="e,602.68,1023.8 602.4,1023.7 602.44,1023.7 602.49,1023.7 602.54,1023.7"];
	" regulator "	[height=0.5,
		pos="553.82,942",
		width=1.3179];
	" cyld " -> " regulator "	[label=" act ",
		lp="575.85,995.14",
		pos="e,557.78,960.04 567.76,1005.4 565.46,994.98 562.53,981.62 559.94,969.85"];
	" negative regulator "	[height=0.5,
		pos="496.8,1060.4",
		width=2.2026];
	" cyld " -> " negative regulator "	[label=" act ",
		lp="531.64,1029.8",
		pos="e,530.22,1043.9 548.03,1035.2 545.2,1036.6 542.25,1038 539.25,1039.5"];
	" mm cells "	[height=0.5,
		pos="623.94,1088.8",
		width=1.354];
	" cyld " -> " mm cells "	[label=" sensitize ",
		lp="621.63,1059",
		pos="e,609.85,1071.2 584.91,1040 590.5,1047 597.15,1055.3 603.36,1063.1"];
	" ligands "	[height=0.5,
		pos="553.78,1105.1",
		width=1.1374];
	" cyld " -> " ligands "	[label=" sensitize mm cells ",
		lp="618.33,1051.9",
		pos="e,557.75,1087.1 567.75,1041.6 565.45,1052.1 562.5,1065.5 559.91,1077.2"];
	" nf-κb-stimuli ligands "	[height=0.5,
		pos="496.52,987.33",
		width=2.5276];
	" cyld " -> " nf-κb-stimuli ligands "	[label=" sensitize mm cells ",
		lp="489.57,1017.7",
		pos="e,531.16,1004 547.94,1012.1 545.44,1010.9 542.84,1009.6 540.2,1008.3"];
	" regulator nf-κb "	[height=0.5,
		pos="624.55,958.8",
		width=1.9318];
	" cyld " -> " regulator nf-κb "	[label=" act ",
		lp="606.24,988.43",
		pos="e,609.92,976.72 585.06,1007.2 590.63,1000.4 597.23,992.28 603.43,984.68"];
	" nsd3 .109 "	[height=0.5,
		pos="1737.9,2786.7",
		width=1.3902];
	" nsd3 .109 " -> " chromatin "	[label=" maintain ",
		lp="1709.5,2747.7",
		pos="e,1737.2,2731.6 1737.6,2768.6 1737.5,2760.5 1737.4,2750.8 1737.3,2741.8"];
	" cyld expression "	[height=0.5,
		pos="113.37,911.21",
		width=1.9679];
	" proliferation study "	[height=0.5,
		pos="157.27,968.63",
		width=2.2567];
	" cyld expression " -> " proliferation study "	[label=" correlate ",
		lp="104.68,943.31",
		pos="e,143.48,950.59 127.02,929.06 130.29,933.34 133.85,938 137.35,942.56"];
	" ndmm "	[height=0.5,
		pos="89.417,843",
		width=1.0832];
	" cyld expression " -> " ndmm "	[label=" strongly correlate ",
		lp="51.5,874.17",
		pos="e,95.689,860.86 106.95,892.93 104.53,886.01 101.71,877.98 99.046,870.41"];
	" low cyld expression "	[height=0.5,
		pos="2208,556.64",
		width=2.4012];
	" proliferation preclinical study "	[height=0.5,
		pos="2279.2,546",
		width=3.34];
	" low cyld expression " -> " proliferation preclinical study "	[label=" correlate ",
		lp="2251.1,553.59",
		pos="e,2279,546.03 2278.4,546.12 2278.5,546.1 2278.6,546.08 2278.7,546.07"];
	" effect "	[height=0.5,
		pos="122.38,449.21",
		width=0.99297];
	" wnt signaling "	[height=0.5,
		pos="166.28,506.63",
		width=1.7693];
	" effect " -> " wnt signaling "	[label=" target ",
		lp="121.39,480.92",
		pos="e,152.67,488.83 135.32,466.12 138.81,470.7 142.68,475.76 146.47,480.71"];
	" piceatannol "	[height=0.5,
		pos="98.425,381",
		width=1.5526];
	" effect " -> " piceatannol "	[label=" target wnt signal ",
		lp="62.617,412.48",
		pos="e,104.76,399.04 116.09,431.29 113.66,424.37 110.82,416.3 108.15,408.67"];
	" nsds "	[height=0.5,
		pos="207.88,1802.2",
		width=0.86659];
	" histone h3 lysine "	[height=0.5,
		pos="251.78,1859.6",
		width=2.0943];
	" nsds " -> " histone h3 lysine "	[label=" methylating ",
		lp="189.68,1833.6",
		pos="e,238.03,1841.6 220.58,1818.8 224.08,1823.4 227.97,1828.5 231.78,1833.5"];
	" histone h4 lysine "	[height=0.5,
		pos="183.92,1734",
		width=2.0943];
	" nsds " -> " histone h4 lysine "	[label=" methylating ",
		lp="161.11,1765.5",
		pos="e,190.26,1752 201.59,1784.3 199.16,1777.4 196.32,1769.3 193.64,1761.7"];
	" synergistic effect "	[height=0.5,
		pos="2826.1,2792.2",
		width=2.1123];
	" wnt signaling acid "	[height=0.5,
		pos="2870,2849.6",
		width=2.2387];
	" synergistic effect " -> " wnt signaling acid "	[label=" target ",
		lp="2825.4,2824.3",
		pos="e,2856.2,2831.6 2839.7,2810.1 2843,2814.3 2846.6,2819 2850,2823.6"];
	" wnt signaling ethacrynic acid "	[height=0.5,
		pos="2802.1,2724",
		width=3.3219];
	" synergistic effect " -> " wnt signaling ethacrynic acid "	[label=" target ",
		lp="2796.3,2755.4",
		pos="e,2808.6,2742.3 2819.7,2773.9 2817.3,2767.1 2814.5,2759.2 2811.9,2751.8"];
	" myeloma set domain "	[height=0.5,
		pos="2080.5,160.64",
		width=2.5276];
	" chromosomal translocation "	[height=0.5,
		pos="2151.7,150",
		width=3.1233];
	" myeloma set domain " -> " chromosomal translocation "	[label=" over-expressed due ",
		lp="2208.2,157.51",
		pos="e,2151.7,150 2151.7,150.01 2151.7,150.01 2151.7,150.01 2151.7,150"];
	" enhances "	[height=0.5,
		pos="1514.9,86.206",
		width=1.336];
	" cells "	[height=0.5,
		pos="1558.8,143.63",
		width=0.88464];
	" enhances " -> " cells "	[label=" expression ",
		lp="1501,118.74",
		pos="e,1546.1,126.98 1528.3,103.75 1531.9,108.48 1535.9,113.69 1539.8,118.74"];
	" cmyc protein "	[height=0.5,
		pos="1490.9,18",
		width=1.7332];
	" enhances " -> " cmyc protein "	[label=" expression ",
		lp="1471.6,49.479",
		pos="e,1497.3,36.038 1508.6,68.286 1506.2,61.37 1503.3,53.298 1500.6,45.672"];
	" subsequent gene expression "	[height=0.5,
		pos="354.27,2344.3",
		width=3.1594];
	" subsequent gene expression " -> " chromatin state "	[label=" global change ",
		lp="315.92,2306.1",
		pos="e,360.6,2291 356.42,2326.2 357.32,2318.6 358.41,2309.5 359.42,2301"];
	" mmset "	[height=0.5,
		pos="2575.8,498.56",
		width=1.1193];
	" mmset " -> " cell growth "	[label=" stimulate ",
		lp="2512.7,491.37",
		pos="e,2527.3,477.68 2546.6,486.01 2543.4,484.62 2540.1,483.18 2536.7,481.74"];
	" histones "	[height=0.5,
		pos="2522.9,571.48",
		width=1.2277];
	" mmset " -> " histones "	[label=" methylation ",
		lp="2588.9,538.29",
		pos="e,2535.5,554.07 2563.2,515.84 2556.8,524.77 2548.7,535.84 2541.5,545.75"];
	" expression cells "	[height=0.5,
		pos="2567.4,582.26",
		width=1.9859];
	" mmset " -> " expression cells "	[label=" enhance ",
		lp="2598.1,527.81",
		pos="e,2569.2,564.13 2573.9,516.72 2572.9,527.58 2571.5,541.61 2570.3,553.9"];
	" methylation "	[height=0.5,
		pos="2503.3,525.62",
		width=1.6068];
	" mmset " -> " methylation "	[label=" regulate ",
		lp="2518.5,502.74",
		pos="e,2540.4,511.74 2544.6,510.19 2544.5,510.22 2544.4,510.25 2544.3,510.29"];
	" expression cmyc protein cells "	[height=0.5,
		pos="2541.9,423.4",
		width=3.358];
	" mmset " -> " expression cmyc protein cells "	[label=" enhance ",
		lp="2587,473.26",
		pos="e,2550.1,441.61 2567.7,480.74 2563.7,471.8 2558.7,460.76 2554.2,450.77"];
	" expression cmyc protein "	[height=0.5,
		pos="2585.4,414",
		width=2.8525];
	" mmset " -> " expression cmyc protein "	[label=" enhance ",
		lp="2606,453.61",
		pos="e,2583.4,432.02 2577.9,480.21 2579.1,469.05 2580.8,454.58 2582.2,442.01"];
	" multiple myeloma set domain "	[height=0.5,
		pos="1080.6,2338.2",
		width=3.4122];
	" multiple myeloma set domain " -> " translocation "	[label=" specifically over-expressed due ",
		lp="1143.7,2371.8",
		pos="e,1039.5,2379.6 1062.8,2356.2 1057.7,2361.3 1052.1,2366.9 1046.7,2372.4"];
	" alteration "	[height=0.5,
		pos="2055.2,1605.6",
		width=1.354];
	" alteration " -> " apoptosis "	[label=" induction ",
		lp="2022.5,1593.7",
		pos="e,2007.4,1601.2 2007.8,1601.2 2007.7,1601.2 2007.7,1601.2 2007.6,1601.2"];
	" terminal family "	[height=0.5,
		pos="279.02,1653.8",
		width=1.9859];
	" proteins "	[height=0.5,
		pos="355.21,1663.3",
		width=1.2277];
	" terminal family " -> " proteins "	[label=" bromodomain ",
		lp="385.89,1669.4",
		pos="e,343.64,1661.9 343.31,1661.9 343.36,1661.9 343.42,1661.9 343.48,1661.9"];
	" extra terminal family "	[height=0.5,
		pos="401.33,1602",
		width=2.5276];
	" extra terminal family " -> " proteins "	[label=" bromodomain ",
		lp="423.63,1636.4",
		pos="e,368.23,1646 387.74,1620.1 383.6,1625.6 378.97,1631.7 374.52,1637.7"];
	" extra family "	[height=0.5,
		pos="1784.7,1216.6",
		width=1.6429];
	" gene transcription "	[height=0.5,
		pos="1855.9,1206",
		width=2.2026];
	" extra family " -> " gene transcription "	[label=" regulate ",
		lp="1812,1216.2",
		pos="e,1838.4,1208.6 1837.9,1208.7 1838,1208.7 1838.1,1208.7 1838.2,1208.6"];
	" family "	[height=0.5,
		pos="384.74,1734.2",
		width=1.0832];
	" family " -> " proteins "	[label=" bromodomain ",
		lp="329.46,1696",
		pos="e,362.76,1681.5 377.29,1716.3 374.06,1708.6 370.21,1699.3 366.64,1690.7"];
	" molecules "	[height=0.5,
		pos="1480.5,1513.6",
		width=1.4443];
	" myeloma "	[height=0.5,
		pos="1551.7,1503",
		width=1.3721];
	" molecules " -> " myeloma "	[label=" first study ",
		lp="1497.5,1499",
		pos="e,1528.7,1506.4 1528.4,1506.5 1528.5,1506.5 1528.5,1506.5 1528.6,1506.5"];
	" removal "	[height=0.5,
		pos="418.55,848.71",
		width=1.2457];
	" acetyl groups lysine residues histones "	[height=0.5,
		pos="494.43,860.49",
		width=4.1344];
	" removal " -> " acetyl groups lysine residues histones "	[label=" addition ",
		lp="486.58,862.74",
		pos="e,460.89,855.28 460.48,855.22 460.55,855.23 460.62,855.24 460.69,855.25"];
	" acetyl groups lysine residues "	[height=0.5,
		pos="391.17,777",
		width=3.2678];
	" removal " -> " acetyl groups lysine residues "	[label=" addition ",
		lp="380.7,810.18",
		pos="e,398.17,795.34 411.64,830.62 408.65,822.78 405.08,813.42 401.76,804.74"];
	" acetyl groups "	[height=0.5,
		pos="370.66,908.7",
		width=1.7512];
	" removal " -> " acetyl groups "	[label=" addition ",
		lp="372.04,881.9",
		pos="e,384.98,890.76 404.7,866.06 400.54,871.27 395.89,877.1 391.39,882.74"];
	" brds "	[height=0.5,
		pos="472.19,1437.7",
		width=0.84854];
	" nucleosomes "	[height=0.5,
		pos="538.88,1394.4",
		width=1.7151];
	" brds " -> " nucleosomes "	[label=" bind ",
		lp="514.75,1427.9",
		pos="e,513.22,1411.1 492.92,1424.2 496.64,1421.8 500.6,1419.2 504.57,1416.7"];
	" transcription factors "	[height=0.5,
		pos="429.03,1371",
		width=2.4012];
	" brds " -> " transcription factors "	[label=" recognize ",
		lp="423.25,1401.7",
		pos="e,440.67,1389 461.3,1420.8 456.73,1413.8 451.3,1405.4 446.21,1397.5"];
	" acetylated nucleosomes "	[height=0.5,
		pos="405.97,1481.5",
		width=2.7623];
	" brds " -> " acetylated nucleosomes "	[label=" bind ",
		lp="430.25,1447.3",
		pos="e,432.4,1464 451.6,1451.3 448.18,1453.6 444.56,1456 440.9,1458.4"];
	" transcription factors inhibitors demonstrated "	[height=0.5,
		pos="516.03,1504",
		width=4.8024];
	" brds " -> " transcription factors inhibitors demonstrated "	[label=" recognize ",
		lp="521.41,1458.5",
		pos="e,504.01,1485.8 483.48,1454.7 488,1461.6 493.32,1469.6 498.34,1477.2"];
	" jq-1 "	[height=0.5,
		pos="2440.3,218.21",
		width=0.83048];
	" interaction "	[height=0.5,
		pos="2484.2,275.63",
		width=1.4804];
	" jq-1 " -> " interaction "	[label=" selectively inhibit ",
		lp="2406.2,249.78",
		pos="e,2470.8,258.05 2453,234.81 2456.6,239.48 2460.6,244.67 2464.4,249.74"];
	" interaction bet proteins "	[height=0.5,
		pos="2416.4,150",
		width=2.69];
	" jq-1 " -> " interaction bet proteins "	[label=" inhibit ",
		lp="2408.6,181.48",
		pos="e,2422.7,168.04 2434,200.29 2431.6,193.37 2428.8,185.3 2426.1,177.67"];
	" positive effects "	[height=0.5,
		pos="2555.7,1904.7",
		width=1.9318];
	" selective small molecule bromodomain inhibitor "	[height=0.5,
		pos="2631.6,1916.5",
		width=5.2356];
	" positive effects " -> " selective small molecule bromodomain inhibitor "	[label=" .124 ",
		lp="2599.6,1921.5",
		pos="e,2616,1914.1 2615.5,1914 2615.6,1914 2615.7,1914 2615.8,1914"];
	" selective molecule bromodomain inhibitor "	[height=0.5,
		pos="2528.4,1833",
		width=4.6399];
	" positive effects " -> " selective molecule bromodomain inhibitor "	[label=" .124 ",
		lp="2527.9,1866.2",
		pos="e,2535.4,1851.3 2548.8,1886.6 2545.8,1878.8 2542.3,1869.4 2539,1860.7"];
	" small molecule bromodomain inhibitor "	[height=0.5,
		pos="2507.9,1964.7",
		width=4.3149];
	" positive effects " -> " small molecule bromodomain inhibitor "	[label=" .124 ",
		lp="2519.1,1938",
		pos="e,2522.4,1946.5 2541.6,1922.4 2537.6,1927.5 2533,1933.2 2528.6,1938.7"];
	" signal "	[height=0.5,
		pos="1560.4,693.11",
		width=1.011];
	" different partners "	[height=0.5,
		pos="1642,714.62",
		width=2.1304];
	" signal " -> " different partners "	[label=" recruit ",
		lp="1614.2,694.13",
		pos="e,1592.9,701.69 1592.6,701.62 1592.7,701.63 1592.7,701.64 1592.8,701.65"];
	" different molecular partners including chromatin factors "	[height=0.5,
		pos="1519.1,619.44",
		width=5.9759];
	" signal " -> " different molecular partners including chromatin factors "	[label=" recruit ",
		lp="1520.9,653.57",
		pos="e,1529.2,637.54 1550.6,675.65 1545.7,666.95 1539.7,656.22 1534.3,646.48"];
	" partners "	[height=0.5,
		pos="1487.3,735.11",
		width=1.2277];
	" signal " -> " partners "	[label=" recruit ",
		lp="1507.7,703.57",
		pos="e,1513.1,720.31 1536.5,706.86 1531.8,709.56 1526.8,712.43 1521.9,715.27"];
	" molecular partners "	[height=0.5,
		pos="1603,765.9",
		width=2.2748];
	" signal " -> " molecular partners "	[label=" recruit ",
		lp="1557.5,732.48",
		pos="e,1592.5,747.94 1570.7,710.73 1575.7,719.28 1581.8,729.73 1587.4,739.22"];
	" different molecular partners "	[height=0.5,
		pos="1538.9,774.54",
		width=3.1775];
	" signal " -> " different molecular partners "	[label=" recruit ",
		lp="1540.2,721.45",
		pos="e,1543.6,756.52 1555.6,711.18 1552.9,721.62 1549.3,734.97 1546.2,746.72"];
	" molecular partners including chromatin factors "	[height=0.5,
		pos="1479.2,670.64",
		width=5.0732];
	" signal " -> " molecular partners including chromatin factors "	[label=" recruit ",
		lp="1506.7,691.71",
		pos="e,1528,684.16 1528.3,684.23 1528.3,684.22 1528.2,684.21 1528.2,684.19"];
	" different partners including chromatin factors "	[height=0.5,
		pos="1633.6,650.82",
		width=4.9107];
	" signal " -> " different partners including chromatin factors "	[label=" recruit ",
		lp="1567.8,683.95",
		pos="e,1602.9,668.56 1584.4,679.27 1587.5,677.45 1590.8,675.55 1594.1,673.63"];
	" partners including chromatin factors "	[height=0.5,
		pos="1582.7,612",
		width=4.008];
	" signal " -> " partners including chromatin factors "	[label=" recruit ",
		lp="1591.7,665.04",
		pos="e,1577.7,630.23 1565.4,675.11 1568.2,664.79 1571.8,651.6 1575,639.96"];
	" bet inhibition "	[height=0.5,
		pos="1119.6,1691.6",
		width=1.7512];
	" bet inhibition " -> " myc "	[label=" downregulates ",
		lp="1167.6,1739.8",
		pos="e,1127.6,1765.1 1121.6,1709.7 1123,1722.6 1124.9,1740.2 1126.5,1755"];
	" bet inhibition " -> " mm cell lines "	[label=" increase lenalidomide/dexamethasone efficacy ",
		lp="997.79,1660.1",
		pos="e,1136,1622 1123.9,1673.4 1126.7,1661.4 1130.5,1645.4 1133.7,1631.8"];
	" mm cell proliferation "	[height=0.5,
		pos="1056.8,1721.3",
		width=2.5456];
	" bet inhibition " -> " mm cell proliferation "	[label=" inhibit ",
		lp="1065.1,1714.7",
		pos="e,1086.4,1707.3 1086.7,1707.1 1086.7,1707.2 1086.6,1707.2 1086.6,1707.2"];
	" mm cell proliferation including mm cell lines "	[height=0.5,
		pos="1030.3,1688.4",
		width=4.9648];
	" bet inhibition " -> " mm cell proliferation including mm cell lines "	[label=" inhibit ",
		lp="1035,1681.9",
		pos="e,1056.2,1689.4 1056.6,1689.4 1056.5,1689.4 1056.5,1689.4 1056.4,1689.4"];
	" lenalidomide/dexamethasone efficacy "	[height=0.5,
		pos="1194.8,1715",
		width=4.1524];
	" bet inhibition " -> " lenalidomide/dexamethasone efficacy "	[label=" increase ",
		lp="1188.6,1697.5",
		pos="e,1162.9,1705.1 1162.5,1705 1162.5,1705 1162.6,1705 1162.7,1705"];
	" molecule "	[height=0.5,
		pos="2821.5,1637.2",
		width=1.336];
	" overall survival "	[height=0.5,
		pos="2865.4,1694.6",
		width=1.9679];
	" molecule " -> " overall survival "	[label=" increase ",
		lp="2814.2,1669.2",
		pos="e,2851.8,1676.8 2834.9,1654.7 2838.3,1659.1 2841.9,1663.9 2845.5,1668.6"];
	" immunoglobulin expression "	[height=0.5,
		pos="2797.6,1569",
		width=3.1955];
	" molecule " -> " immunoglobulin expression "	[label=" reduce ",
		lp="2789.3,1600.5",
		pos="e,2803.9,1587 2815.2,1619.3 2812.8,1612.4 2810,1604.3 2807.3,1596.7"];
	" human mm cell lines "	[height=0.5,
		pos="1096.1,1548.3",
		width=2.5276];
	" human mm cell lines " -> " inhibition "	[label=" bet ",
		lp="1095.4,1537.6",
		pos="e,1112.4,1523.1 1107.7,1530.3 1107.8,1530.2 1107.9,1530 1108,1529.9"];
	" bet inhibitor otx015 "	[height=0.5,
		pos="453.18,119.21",
		width=2.3831];
	" phase trials "	[height=0.5,
		pos="497.07,176.63",
		width=1.5526];
	" bet inhibitor otx015 " -> " phase trials "	[label=" antiproliferative activity ",
		lp="402.59,151.44",
		pos="e,483.59,158.98 466.83,137.06 470.16,141.42 473.8,146.18 477.35,150.83"];
	" currently phase trials "	[height=0.5,
		pos="429.22,51",
		width=2.4914];
	" bet inhibitor otx015 " -> " currently phase trials "	[label=" antiproliferative activity ",
		lp="373.37,82.351",
		pos="e,435.66,69.328 446.76,100.93 444.37,94.124 441.6,86.24 438.98,78.774"];
	" apoptosis caspase-dependent cell death "	[height=0.5,
		pos="2637.9,2247.8",
		width=4.2607];
	" inhibition myc "	[height=0.5,
		pos="2714.1,2257.3",
		width=1.8776];
	" apoptosis caspase-dependent cell death " -> " inhibition myc "	[label=" associate ",
		lp="2685.6,2264.8",
		pos="e,2714.1,2257.3 2714.1,2257.3 2714.1,2257.3 2714.1,2257.3 2714.1,2257.3"];
	" cpi-0610 "	[height=0.5,
		pos="1063.5,529.51",
		width=1.2999];
	" apoptosis associated "	[height=0.5,
		pos="1134.8,488.01",
		width=2.4192];
	" cpi-0610 " -> " apoptosis associated "	[label=" induce ",
		lp="1115,519.82",
		pos="e,1105.3,505.19 1089.6,514.29 1091.9,513 1094.1,511.67 1096.4,510.34"];
	" caspase-dependent cell death "	[height=0.5,
		pos="1063.3,447",
		width=3.2858];
	" cpi-0610 " -> " caspase-dependent cell death "	[label=" induce ",
		lp="1041.4,500.88",
		pos="e,1063.3,465.26 1063.4,511.2 1063.4,500.73 1063.4,487.37 1063.3,475.55"];
	" cell death "	[height=0.5,
		pos="992.71,571.96",
		width=1.3902];
	" cpi-0610 " -> " cell death "	[label=" induce ",
		lp="1010.6,540.53",
		pos="e,1018.4,556.52 1037.9,544.84 1034.4,546.92 1030.8,549.08 1027.3,551.23"];
	" apoptosis associated inhibition myc "	[height=0.5,
		pos="1135.4,570.05",
		width=3.9358];
	" cpi-0610 " -> " apoptosis associated inhibition myc "	[label=" induce ",
		lp="1114.5,538.37",
		pos="e,1104.2,552.44 1089.8,544.38 1091.6,545.36 1093.4,546.36 1095.2,547.37"];
	" g1 cell cycle arrest "	[height=0.5,
		pos="1064.9,612.07",
		width=2.2929];
	" cpi-0610 " -> " g1 cell cycle arrest "	[label=" induce ",
		lp="1086.1,558.17",
		pos="e,1064.6,593.8 1063.8,547.83 1064,558.31 1064.2,571.67 1064.4,583.5"];
	" apoptosis associated inhibition "	[height=0.5,
		pos="991.67,488.9",
		width=3.4483];
	" cpi-0610 " -> " apoptosis associated inhibition "	[label=" induce ",
		lp="1012.5,520.62",
		pos="e,1022.9,506.54 1037.1,514.62 1035.4,513.63 1033.6,512.63 1031.8,511.62"];
	" antiproliferative activity "	[height=0.5,
		pos="1298.3,119.21",
		width=2.7984];
	" brd motifs "	[height=0.5,
		pos="1342.2,176.63",
		width=1.4624];
	" antiproliferative activity " -> " brd motifs "	[label=" bind ",
		lp="1301.2,151.44",
		pos="e,1328.7,158.98 1311.9,137.06 1315.3,141.42 1318.9,146.18 1322.4,150.83"];
	" binding "	[height=0.5,
		pos="1274.3,51",
		width=1.1735];
	" antiproliferative activity " -> " binding "	[label=" act ",
		lp="1275.9,82.171",
		pos="e,1280.6,68.856 1291.9,100.93 1289.4,94.014 1286.6,85.985 1283.9,78.414"];
	" apoptosis cell death "	[height=0.5,
		pos="2760.2,2196",
		width=2.3651];
	" apoptosis cell death " -> " inhibition myc "	[label=" associate ",
		lp="2711.6,2215.2",
		pos="e,2727.4,2239.6 2746.6,2214.1 2742.6,2219.5 2738,2225.5 2733.6,2231.4"];
	" cpi-0610 apoptosis "	[height=0.5,
		pos="2743.6,2328.2",
		width=2.2929];
	" cpi-0610 apoptosis " -> " inhibition myc "	[label=" associate ",
		lp="2702.3,2289.9",
		pos="e,2721.6,2275.3 2736,2309.9 2732.8,2302.3 2729.1,2293.2 2725.5,2284.8"];
	" recent advancements "	[height=0.5,
		pos="815.48,672.46",
		width=2.4914];
	" recent advancements " -> " mm "	[label=" novel aberrant pathways ",
		lp="824.35,651.76",
		pos="e,753.48,659.18 753.98,659.29 753.9,659.27 753.81,659.26 753.73,659.24"];
	" therapies "	[height=0.5,
		pos="121.88,2462.2",
		width=1.3179];
	" dna methylation "	[height=0.5,
		pos="165.77,2519.6",
		width=2.0401];
	" therapies " -> " dna methylation "	[label=" target ",
		lp="121.08,2494.2",
		pos="e,152.15,2501.8 135.29,2479.7 138.63,2484.1 142.28,2488.9 145.86,2493.6"];
	" histone modification "	[height=0.5,
		pos="97.923,2394",
		width=2.4553];
	" therapies " -> " histone modification "	[label=" target ",
		lp="92.114,2425.5",
		pos="e,104.26,2412 115.59,2444.3 113.16,2437.4 110.32,2429.3 107.64,2421.7"];
	" .135 recent advancements "	[height=0.5,
		pos="774.21,727.89",
		width=2.997];
	" .135 recent advancements " -> " mm "	[label=" novel molecular pathways ",
		lp="832.53,703.25",
		pos="e,744.62,672.55 764.62,709.95 760.04,701.39 754.47,690.97 749.43,681.54"];
	" dysregulation "	[height=0.5,
		pos="1813.6,2033.2",
		width=1.7693];
	" pathogenesis malignancies "	[height=0.5,
		pos="1857.5,2090.6",
		width=3.0692];
	" dysregulation " -> " pathogenesis malignancies "	[label=" increasingly recognize ",
		lp="1767.4,2065.3",
		pos="e,1843.7,2072.6 1827.3,2051.1 1830.5,2055.3 1834.1,2060 1837.6,2064.6"];
	" pathogenesis hematological malignancies "	[height=0.5,
		pos="1789.7,1965",
		width=4.5315];
	" dysregulation " -> " pathogenesis hematological malignancies "	[label=" increasingly recognize ",
		lp="1738.4,1996.5",
		pos="e,1796,1983 1807.3,2015.3 1804.9,2008.4 1802.1,2000.3 1799.4,1992.7"];
	" epigenetic therapies "	[height=0.5,
		pos="312.47,2693.2",
		width=2.3831];
	" posttranslational histone modification "	[height=0.5,
		pos="356.37,2750.6",
		width=4.1344];
	" epigenetic therapies " -> " posttranslational histone modification "	[label=" target ",
		lp="311.78,2725.3",
		pos="e,342.58,2732.6 326.12,2711.1 329.39,2715.3 332.95,2720 336.44,2724.6"];
	" acetylation "	[height=0.5,
		pos="288.51,2625",
		width=1.4985];
	" epigenetic therapies " -> " acetylation "	[label=" target ",
		lp="282.66,2656.4",
		pos="e,294.95,2643.3 306.05,2674.9 303.66,2668.1 300.89,2660.2 298.27,2652.8"];
	" novel inhibitor cg13250 "	[height=0.5,
		pos="143.27,2156.5",
		width=2.7984];
	" myc transcription "	[height=0.5,
		pos="187.29,2099.2",
		width=2.1665];
	" novel inhibitor cg13250 " -> " myc transcription "	[label=" suppress ",
		lp="134.85,2124.1",
		pos="e,173.6,2117 157.2,2138.3 160.47,2134.1 164.03,2129.5 167.5,2124.9"];
	" inhibitor cg13250 "	[height=0.5,
		pos="211.4,2031",
		width=2.1845];
	" inhibitor cg13250 " -> " myc transcription "	[label=" suppress ",
		lp="173.52,2067.8",
		pos="e,193.77,2080.8 204.94,2049.3 202.53,2056.1 199.75,2063.9 197.11,2071.4"];
	" targets "	[height=0.5,
		pos="2671.3,508.02",
		width=1.0832];
	" targets " -> " mmset "	[label=" include ",
		lp="2641.3,496.36",
		pos="e,2615.3,502.47 2633,504.22 2630.5,503.98 2628,503.73 2625.5,503.49"];
	" bet "	[height=0.5,
		pos="2716.4,431.44",
		width=0.75];
	" targets " -> " bet "	[label=" include ",
		lp="2667.4,481.34",
		pos="e,2706.5,448.22 2681.5,490.64 2687.4,480.71 2694.8,468.08 2701.3,457.03"];
	" cyclin "	[height=0.5,
		pos="2671.6,427.18",
		width=1.0291];
	" targets " -> " cyclin "	[label=" include ",
		lp="2671.4,465.2",
		pos="e,2671.6,445.45 2671.4,489.67 2671.4,479.65 2671.5,467.01 2671.5,455.73"];
	" bcl-2 "	[height=0.5,
		pos="2652.8,583.35",
		width=0.93881];
	" targets " -> " bcl-2 "	[label=" include ",
		lp="2651.2,533.4",
		pos="e,2657.3,565.28 2666.8,526.25 2664.7,535.04 2662,545.78 2659.6,555.56"];
	" mdm2 "	[height=0.5,
		pos="2754,519.27",
		width=1.0832];
	" targets " -> " mdm2 "	[label=" include ",
		lp="2709,505.65",
		pos="e,2716.5,514.17 2708.8,513.12 2708.9,513.14 2709.1,513.16 2709.3,513.18"];
	" nras "	[height=0.5,
		pos="2734.2,564.9",
		width=0.84854];
	" targets " -> " nras "	[label=" include ",
		lp="2675.4,540.93",
		pos="e,2717.4,549.69 2689.1,524.17 2695.5,529.93 2702.8,536.52 2709.7,542.7"];
	" kras "	[height=0.5,
		pos="2695.4,596.09",
		width=0.84854];
	" targets " -> " kras "	[label=" include ",
		lp="2658,554.76",
		pos="e,2690.5,578.17 2676.3,526.27 2679.6,538.39 2684,554.55 2687.8,568.26"];
	" braf mek "	[height=0.5,
		pos="2746.6,469.87",
		width=1.336];
	" targets " -> " braf mek "	[label=" include ",
		lp="2727.1,499.39",
		pos="e,2717.8,484.44 2697.6,494.68 2701.2,492.87 2704.9,490.98 2708.6,489.1"];
	" bez235 "	[height=0.5,
		pos="1701.9,2312.8",
		width=1.1374];
	" bez235 " -> " studies "	[label=" display antimyeloma activity ",
		lp="1647.3,2340.6",
		pos="e,1746.3,2344 1723.7,2328.1 1728.2,2331.3 1733.1,2334.7 1737.9,2338.1"];
	" sc99 "	[height=0.5,
		pos="1635.7,2275.7",
		width=0.88464];
	" bez235 " -> " sc99 "	[label=" display antimyeloma activity at_time ",
		lp="1565.8,2303.5",
		pos="e,1658.3,2288.4 1676.5,2298.6 1673.4,2296.9 1670.3,2295.1 1667.1,2293.3"];
	" danfin "	[height=0.5,
		pos="2718,744.66",
		width=1.0471];
	" potent antimyeloma activity "	[height=0.5,
		pos="2784.7,701.42",
		width=3.2136];
	" danfin " -> " potent antimyeloma activity "	[label=" display ",
		lp="2768.3,734.8",
		pos="e,2757.5,719.04 2740.6,730.02 2743.3,728.25 2746.1,726.42 2749,724.57"];
	" antimyeloma activity "	[height=0.5,
		pos="2674.8,678",
		width=2.5276];
	" danfin " -> " antimyeloma activity "	[label=" display ",
		lp="2675.9,723.4",
		pos="e,2686.5,696.09 2706.7,727.14 2702.2,720.27 2697,712.22 2692.1,704.66"];
	" various studies "	[height=0.5,
		pos="2651.8,788.51",
		width=1.8957];
	" danfin " -> " various studies "	[label=" display antimyeloma activity ",
		lp="2607.3,755.14",
		pos="e,2677.2,771.7 2695.9,759.26 2692.7,761.44 2689.2,763.73 2685.7,766.03"];
	" various preclinical studies "	[height=0.5,
		pos="2761.8,810.97",
		width=2.997];
	" danfin " -> " various preclinical studies "	[label=" display antimyeloma activity ",
		lp="2820.4,780.76",
		pos="e,2749.9,792.97 2729.5,762.08 2734,768.92 2739.3,776.92 2744.3,784.45"];
	" vemurafenib "	[height=0.5,
		pos="1982.1,2275.7",
		width=1.679];
	" vemurafenib " -> " preclinical studies "	[label=" display antimyeloma activity ",
		lp="1837.8,2282.9",
		pos="e,1921.1,2275.4 1921.3,2275.4 1921.3,2275.4 1921.3,2275.4 1921.2,2275.4"];
}
